Exclusions for E4_PCOS_BROAD

E4_PCOS_BROAD_EXCLUSIONS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C74, D35.2&, E22, E23, E24, E25, E27, Q96 Hospital discharge: ICD-9 — 2273\|253\|255\|6116\|2270\|194 Hospital discharge: ICD-8 — 2262\|253\|255\|258\|2260 Cause of death: ICD-10 — C74, D35.2&, E22, E23, E24, E25, E27, Q96 Cause of death: ICD-9 — 2273\|253\|255\|6116\|2270\|194 Cause of death: ICD-8 — 2262\|253\|255\|258\|2260 2 out of 7 registries used, show all original rules.	8958
4. Check minimum number of events None	8958
5. Include endpoints None	8958
6. Filter based on genotype QC (FinnGen only)	7949

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF6v3

NAME	E4_PCOS_BROAD_EXCLUSIONS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D352\|E22\|E23\|E24\|E25\|E27\|Q96\|C74\|E221
HD_ICD_9	2273\|253\|255\|6116\|2270\|194
HD_ICD_8	2262\|253\|255\|258\|2260
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D352\|E22\|E23\|E24\|E25\|E27\|Q96\|C74\|E221
COD_ICD_9	2273\|253\|255\|6116\|2270\|194
COD_ICD_8	2262\|253\|255\|258\|2260
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Exclusions for E4_PCOS_BROAD based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7949	4598	3351
Unadjusted period prevalence (%)	1.59	1.63	1.54
Median age at first event (years)	46.97	42.20	53.53

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8331: Matched controls
83225

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

102

Kela drug reimbursment

Diabetes insipidus

1045.8

311.1

303

101

Kela drug reimbursment

Anterior pituitary hypofunction

440.1

307.7

1141

H03AA01

ATC

levothyroxine sodium; systemic

3.3

307.7

2849

11422

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

2105.8

307.7

727

H01AC01

ATC

somatropin; parenteral

78.7

307.7

419

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

10.4

307.7

1632

1908

H02AA02

ATC

fludrocortisone; oral

30.9

307.7

407

138

H02AB09

ATC

hydrocortisone; systemic

53.9

307.7

2423

629

AA4DG

NOMESCO Finland

Very extensive MRI examination of sella turcica with high intensity magnet

132.7

307.7

182

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

112.0

307.7

1283

135

N04BC06

ATC

cabergoline; oral

136.6

307.7

632

G02CB01

ATC

bromocriptine; systemic

14.1

307.7

592

450

D44.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pituitary gland

190.4

307.7

312

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

684.9

307.7

455

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

8.0

307.7

506

664

E23.2

ICD-10 Finland

Diabetes insipidus

564.5

307.7

327

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

1034.8

307.7

668

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

184.7

307.7

1414

G02CB03

ATC

cabergoline; oral

28.5

307.7

252

AA4BG

NOMESCO Finland

MRI examination of sella turcica with high intensity magnet

412.4

307.7

358

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

11824.7

307.7

1870

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

8.2

307.7

938

1270

E23.03

ICD-10 Finland

Lack of ACTH

3355.4

307.7

333

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

307.7

675

E22.1

ICD-10 Finland

Hyperprolactinaemia

1021.1

307.7

1438

105

Kela drug reimbursment

Adrenal cortical hypofunction

494.7

307.7

380

E23.05

ICD-10 Finland

Lack of TSH

307.1

307.7

437

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

998.2

307.7

472

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.1

301.7

665

1382

ZXC86

NOMESCO Finland

Use of endoscopic device

21.8

299.8

223

105

301

Kela drug reimbursment

Growth hormone

43.0

296.2

177

186

Kela drug reimbursment

Growth retardation associated with renal failure (growth hormone)

122.8

285.7

145

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

31.0

282.9

185

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

2533.3

265.7

256

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

9.3

253.4

309

343

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

11.2

249.4

266

245

E29.1

ICD-10 Finland

Testicular hypofunction

8.2

248.7

336

424

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

236.5

1134

4052

E23.06

ICD-10 Finland

Empty sella

+∞

235.4

225

E22.0

ICD-10 Finland

Acromegaly and pituitary gigantism

2206.9

233.1

225

Y28

ICPC

Limited function/disability (Y)

19.3

232.7

182

D35.31

ICD-10 Finland

Cyst in Rathke's pocket

48.8

224.0

130

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

24.9

218.6

154

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

7.5

213.0

312

432

E27.0

ICD-10 Finland

Other adrenocortical overactivity

362.8

212.9

214

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.6

206.4

1390

5919

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.4

204.7

807

2555

AA4CM

NOMESCO Finland

Extensive MRI examination of sella turcica with 3 Tesla magnet

415.2

204.1

204

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

1011.8

202.8

198

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.3

201.9

345

563

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

177.8

1809

9204

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

173.5

2548

14882

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

172.2

3984

27098

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

4.2

170.7

479

1199

AA1AD

NOMESCO Finland

CT of head and brain

2.0

170.7

2431

14029

N91.1

ICD-10 Finland

Secondary amenorrhoea

5.6

167.8

327

605

E23.09

ICD-10 Finland

Pituitary insufficiency NOS

335.4

164.6

166

R53

ICD-10 Finland

Malaise and fatigue

2.0

164.1

2459

14415

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

163.5

2701

16370

H53.4

ICD-10 Finland

Visual field defects

5.5

158.4

311

579

E24.9

ICD-10 Finland

Cushing syndrome, unspecified

320.6

154.2

156

BCA30

NOMESCO Finland

Unilateral adrenalectomy

40.8

153.7

E27.2

ICD-10 Finland

Addisonian crisis

1515.5

150.4

146

G47.3

ICD-10 Finland

Sleep apnoea

2.0

149.9

2142

12285

T99

ICPC

Endocr/metab/nutrit disease other

6.0

149.0

267

456

XCK00

NOMESCO Finland

Perimetry

3.1

142.1

626

2107

E34.35

ICD-10 Finland

Abnormal growth retardation

11.0

141.6

152

141

N06AX21

ATC

duloxetine; oral

2.3

139.4

1227

5826

N05AH04

ATC

quetiapine; oral

2.0

138.2

1789

9867

C03CA01

ATC

furosemide; systemic

1.9

134.5

2119

12495

N06AX16

ATC

venlafaxine; oral

2.1

134.0

1452

7487

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

129.6

2089

12389

R06.0

ICD-10 Finland

Dyspnoea

1.9

124.1

2269

13979

E24.0

ICD-10 Finland

Pituitary-dependent Cushing disease

+∞

121.1

116

R51.80

ICD-10 Finland

Headache

2.0

120.2

1607

8916

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

119.5

1106

5339

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

13.9

119.2

110

E24.8

ICD-10 Finland

Other Cushing syndrome

+∞

117.9

113

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

117.0

1853

10874

N06AX11

ATC

mirtazapine; oral

1.7

116.6

2917

19646

E23.6

ICD-10 Finland

Other disorders of pituitary gland

+∞

115.8

111

E27.9

ICD-10 Finland

Disorder of adrenal gland, unspecified

575.5

115.2

114

E23.02

ICD-10 Finland

Neurosecretory dysfunction of the growth hormone

+∞

113.7

109

N05BA04

ATC

oxazepam; oral

1.8

113.2

2243

14096

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

109.2

1714

10002

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

108.9

952

4480

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

107.9

1057

5207

E27.5

ICD-10 Finland

Adrenomedullary hyperfunction

+∞

107.5

103

N03AX16

ATC

[U] pregabalin

1.8

107.1

1884

11388

WVA30, ,

SPAT

2.6

106.4

657

2640

UJF32

NOMESCO Finland

Coloscopy

1.8

106.0

2036

12636

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

105.4

1342

7286

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

104.5

958

4593

A55

ICPC

General and Unspecified, Local injection/infiltration

5.3

103.8

211

405

C74.9

ICD-10 Finland

Malignant neoplasm: Adrenal gland, unspecified

+∞

103.3

H02AB06

ATC

prednisolone; systemic

1.6

103.0

3835

28426

N03AX09

ATC

lamotrigine; oral

2.7

102.3

579

2226

2273A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)

+∞

101.2

E22.80

ICD-10 Finland

Central precocious puberty

503.5

100.7

100

A02BC02

ATC

pantoprazole; systemic

1.7

100.6

5419

43941

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

99.0

2019

12715

N03AX12

ATC

[U] gabapentin; oral

2.0

98.8

1354

7527

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

98.4

1309

7202

C74.0

ICD-10 Finland

Malignant neoplasm: Cortex of adrenal gland

+∞

98.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

97.4

1282

7026

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

96.5

1840

11350

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

96.4

1364

7659

N02AX02

ATC

tramadol; systemic, rectal

1.6

96.3

3367

24439

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

96.1

861

4082

ZXC95

NOMESCO Finland

Use of surgical navigator

5.6

96.0

183

331

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

95.5

2175

14111

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.0

91.6

1125

6008

N05CF01

ATC

zopiclone; oral

1.7

90.4

2431

16446

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

88.7

962

4907

C74.1

ICD-10 Finland

Malignant neoplasm: Medulla of adrenal gland

+∞

88.7

Z3231

NOMESCO Finland

Registered nurse

1.7

88.6

2284

15267

R03BB04

ATC

tiotropium bromide; inhalant

2.2

88.4

775

3637

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

87.8

974

5009

R11

ICD-10 Finland

Nausea and vomiting

2.1

86.6

869

4302

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.3

86.1

698

3169

N06AB04

ATC

citalopram; systemic

1.8

85.3

1681

10421

N02AA05

ATC

oxycodone; systemic

1.9

85.3

1324

7636

L28

ICPC

Limited function/disability (L)

1.8

85.1

1428

8438

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

84.0

784

3771

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

83.9

500

1969

C03DA01

ATC

spironolactone; oral

2.1

83.6

939

4848

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

82.4

643

2869

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

82.3

1051

5676

N05AH03

ATC

olanzapine; systemic

2.3

81.7

642

2873

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

81.6

2009

13221

J01MA12

ATC

levofloxacin; systemic

1.8

81.5

1404

8352

R50.9

ICD-10 Finland

Fever, unspecified

1.8

81.4

1392

8261

C07AB07

ATC

bisoprolol; oral

1.6

81.3

3359

25063

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

81.0

1113

6161

N03AE01

ATC

clonazepam; systemic

2.5

80.6

532

2201

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

80.5

1783

11397

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

80.4

674

3101

N05BA01

ATC

diazepam; systemic, rectal

2.0

79.9

1055

5760

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

78.8

834

4206

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

78.0

1326

7847

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

77.9

847

4314

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

77.9

3144

23267

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

77.9

1690

10731

N06AA09

ATC

amitriptyline; systemic

2.2

77.8

746

3623

E25.9

ICD-10 Finland

Adrenogenital disorder, unspecified

764.8

77.4

G03DB01

ATC

dydrogesterone; oral

1.9

77.3

1033

5659

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

3.2

76.9

323

1052

N03AG01

ATC

valproic acid; systemic, rectal

2.4

76.6

582

2566

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

75.6

3082

22818

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

75.5

443

1730

A06AD11

ATC

lactulose; oral

1.9

75.5

1052

5842

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

75.0

1579

9930

N05CD07

ATC

temazepam; oral

2.1

74.8

814

4145

E66.8

ICD-10 Finland

Other obesity

2.3

74.6

575

2550

J01FF01

ATC

clindamycin; systemic

1.6

74.6

2132

14520

A02BC05

ATC

esomeprazole; systemic

1.5

74.3

3123

23253

D35.30

ICD-10 Finland

Craniopharyngoma

734.2

74.3

H01CB02

ATC

octreotide; parenteral

13.0

74.1

N06AB10

ATC

escitalopram; oral

1.7

74.0

1819

11919

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

73.3

1206

7056

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

3.4

73.1

269

808

E23.0

ICD-10 Finland

Hypopituitarism

+∞

73.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

72.7

3083

22972

R42

ICD-10 Finland

Dizziness and giddiness

1.7

72.6

1756

11449

SPAT1262

SPAT

Handing over of treatment supplies

1.8

72.4

1286

7695

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.4

72.1

269

815

G02CB04

ATC

quinagolide; oral

153.2

72.0

TAB00

NOMESCO Finland

Lumbar puncture

2.5

71.5

459

1872

R03DC03

ATC

montelukast; oral

1.7

71.4

1437

8911

J01MA02

ATC

ciprofloxacin; systemic

1.5

71.3

2849

20931

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

70.9

839

4400

N05AX12

ATC

aripiprazole; systemic

2.5

69.7

454

1864

A41.9

ICD-10 Finland

Sepsis, unspecified

3.0

69.5

327

1136

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

69.4

1110

6430

E23

ICD-10 Finland

Hypofunction and other disorders of pituitary gland

181.4

69.1

E23.08

ICD-10 Finland

Hypopituitarism

344.8

68.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

68.5

618

2924

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

68.4

2681

19571

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

68.2

545

2452

H01CB03

ATC

lanreotide; parenteral

13.1

68.1

E27.8

ICD-10 Finland

Other specified disorders of adrenal gland

+∞

67.8

H47.2

ICD-10 Finland

Optic atrophy

8.9

67.7

A02BC01

ATC

omeprazole; systemic

1.6

67.7

2025

13890

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

67.3

941

5220

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

67.2

571

2636

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.0

66.6

143

288

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

66.6

3419

26380

T28

ICPC

Limited function/disability (T)

5.5

66.6

129

237

SPAT1254

SPAT

Administration of medicine

1.8

66.5

1188

7107

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

171.2

65.0

R03AC02

ATC

salbutamol; inhalant

1.5

65.0

4458

36388

N05AA02

ATC

levomepromazine; systemic

2.7

65.0

372

1434

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

64.4

635

3109

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

64.3

517

2331

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

64.3

1507

9709

C07AA05

ATC

propranolol; systemic

1.6

64.0

1650

10891

2542

FHL

Transasal hypophysectomy

+∞

63.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

63.3

2108

14784

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

63.1

472

2063

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

5.8

62.8

114

197

J46

ICD-10 Finland

Status asthmaticus

3.0

62.5

288

989

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

62.3

2040

14244

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

62.1

860

4749

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

62.0

3356

26053

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

61.5

745

3931

25898

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Alii definiti

+∞

61.5

E23.7

ICD-10 Finland

Disorder of pituitary gland, unspecified

314.9

61.4

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

61.3

1669

11150

E66.00

ICD-10 Finland

Metabolic syndrome

2.3

61.3

494

2230

S18

ICPC

Laceration/cut

1.5

61.1

3559

28005

E89.30

ICD-10 Finland

Postprocedural hypopituitarism

602.0

60.8

318

Kela drug reimbursment

Teriparatide

8.0

60.8

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

60.2

1848

12699

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

60.2

628

3140

N05AX08

ATC

risperidone; systemic

2.0

60.2

682

3515

E87.6

ICD-10 Finland

Hypokalaemia

2.8

59.9

307

1117

N06AB03

ATC

fluoxetine; oral

1.8

59.6

997

5836

M05BA04

ATC

alendronic acid; oral

2.1

59.2

588

2885

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

59.1

1002

5889

J45.8

ICD-10 Finland

Mixed asthma

2.8

59.0

300

1087

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.6

59.0

361

1438

H05AA02

ATC

teriparatide; parenteral

8.3

58.9

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

58.6

813

4489

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

5.3

58.5

118

225

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

58.5

425

1833

N06AX26

ATC

vortioxetine; oral

2.0

58.4

734

3920

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

58.3

420

1805

A07AA02

ATC

nystatin; oral

2.3

58.1

453

2015

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

7.7

58.0

106

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

58.0

1730

11794

104

Kela drug reimbursment

Thyroid insufficiency

2.2

58.0

549

2644

N06AX12

ATC

bupropion; oral

2.0

57.5

711

3776

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

57.0

1672

11349

SPAT1263

SPAT

Sampling

1.5

56.8

3200

24910

WZC30

NOMESCO Finland

Teaching

1.7

56.7

1272

8078

G44.2

ICD-10 Finland

Tension-type headache

1.7

56.5

1157

7169

N05BA06

ATC

lorazepam; systemic, sublingual

2.4

56.4

409

1762

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

56.0

310

1174

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

55.9

291

1068

ZX114

NOMESCO Finland

Intramuscular

3.8

55.7

171

455

SPAT1301

SPAT

No procedures

1.5

55.7

2307

16881

ZX120

NOMESCO Finland

Intravenous

1.9

55.7

733

3975

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.5

55.6

194

563

H02AB04

ATC

methylprednisolone; systemic

1.7

55.5

1089

6666

E22.9

ICD-10 Finland

Hyperfunction of pituitary gland, unspecified

+∞

55.2

C08CA01

ATC

amlodipine; oral

1.5

55.2

2531

18897

N06AB06

ATC

sertraline; oral

1.8

55.2

1003

6009

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

55.0

405

1757

A10BA02

ATC

metformin; oral

1.5

54.8

1907

13438

R03BA05

ATC

fluticasone; inhalant

1.6

54.7

1483

9867

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

54.6

4070

33290

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

54.3

546

2690

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.9

54.2

705

3807

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

53.7

323

1275

R03AC12

ATC

salmeterol; inhalant

2.5

53.7

342

1388

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

53.7

468

2180

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

23.0

53.6

ZXD05

NOMESCO Finland

Urgent procedure

1.5

53.3

2278

16745

N02BE01

ATC

paracetamol; systemic, rectal

1.6

53.2

7065

64460

SPAT1153

SPAT

Removal of sutures

1.5

52.9

2169

15805

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

52.7

5871

51530

E34.30

ICD-10 Finland

Short stature NOS

11.5

52.4

R52.2

ICD-10 Finland

Other chronic pain

2.5

52.3

350

1454

J01DB01

ATC

cefalexin; oral

1.5

52.3

6655

59952

M54.5

ICD-10 Finland

Low back pain

1.4

52.2

2913

22536

25510

ICD-8 Finland

Diseases of adrenal glands, Adrenal cortical hypofunction

+∞

52.1

A02BC03

ATC

lansoprazole; oral

1.5

52.0

1969

14106

R60.0

ICD-10 Finland

Localized oedema

1.8

51.9

934

5573

WX882

NOMESCO Finland

High dependency care

2.6

51.9

312

1232

A46

ICD-10 Finland

Erysipelas

1.7

51.8

1060

6554

UKC02

NOMESCO Finland

Cystoscopy

1.7

51.7

1039

6395

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

51.5

438

2019

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

51.5

1157

7335

BC1AD

NOMESCO Finland

CT of adrenal glands

4.8

51.4

116

244

E30.1

ICD-10 Finland

Precocious puberty

11.9

51.3

E0000UV, ,

ATC

1.4

51.3

3311

26282

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

51.3

872

5118

N06AB05

ATC

paroxetine; oral

2.1

51.1

501

2444

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

51.1

E24.2

ICD-10 Finland

Drug-induced Cushing syndrome

+∞

51.1

25899

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Other and unspecified diseases of endocrine system

+∞

51.1

J01MA14

ATC

moxifloxacin; systemic

1.9

51.0

684

3728

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

51.0

2378

17758

R03DA04

ATC

theophylline; systemic, rectal

2.4

50.9

354

1497

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

50.8

775

4400

R03BA08

ATC

ciclesonide; inhalant

1.9

50.8

700

3849

R55

ICD-10 Finland

Syncope and collapse

1.8

50.5

795

4557

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

50.3

632

3371

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

3.2

49.7

201

640

SPAT1240

SPAT

Therapeutic discussion

1.7

49.7

919

5523

CS494

NOMESCO Finland

Other visual field testing

3.0

49.4

226

773

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

49.3

2981

23335

R02

ICPC

Shortness of breath/dyspnoea

1.7

49.1

1031

6414

N05AN01

ATC

lithium; oral

2.9

49.1

243

868

SPAT1260

SPAT

Consultation of another employee

1.6

49.0

1284

8450

E25.01

ICD-10 Finland

Congenital adrenal hyperplasia

+∞

49.0

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

48.9

750

4265

E34.31

ICD-10 Finland

Short stature, prenatal disorder

15.6

48.5

A02BA02

ATC

ranitidine; systemic

1.6

48.4

1262

8295

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.4

48.3

353

1525

V04CD01

ATC

metyrapone; oral

+∞

47.9

Q96.0

ICD-10 Finland

Karyotype 45,X

+∞

47.9

S97

ICPC

Chronic ulcer skin

2.1

47.9

455

2192

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

47.8

837

4950

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

47.5

1508

10372

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

8.4

47.0

N05BE01

ATC

buspirone; oral

2.7

47.0

267

1025

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

46.9

646

3548

2551A

ICD-9 Finland

Disorders of adrenal glands, Hyperaldosteronism

+∞

46.9

WX402

NOMESCO Finland

General anaesthesia

1.5

46.8

1805

12936

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

46.6

3316

26637

T90

ICPC

Diabetes non-insulin dependent

1.5

46.4

1606

11249

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

46.3

1105

7100

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

46.1

1541

10708

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

4.0

46.1

133

339

T73

ICPC

Neoplasm endocrine other/unspecified

16.3

46.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

45.9

2926

23041

N02BF02

ATC

pregabalin; oral

1.9

45.9

570

3026

2533

FHL

Unilateral removal of additional egg

+∞

45.8

22620

ICD-8 Finland

Benign neoplasm of endocrine glands, Pituitary gland and craniopharyngeal duct (pouch)

+∞

45.8

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

45.8

489

2460

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

45.8

1148

7465

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

45.5

452

2214

M79.6

ICD-10 Finland

Pain in limb

1.4

45.5

3419

27685

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

45.3

731

4216

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

45.0

4240

35618

N06AG02

ATC

moclobemide; oral

2.4

44.9

333

1448

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

44.9

998

6293

N03AX11

ATC

topiramate; oral

2.7

44.8

245

922

E25.00

ICD-10 Finland

Congenital salt-losing adrenal hyperplasia

+∞

44.8

E26.0

ICD-10 Finland

Primary hyperaldosteronism

6.1

44.5

127

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

44.5

716

4126

UDM02

NOMESCO Finland

Sinoscopy

3.0

44.3

203

695

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

44.2

804

4803

SPAT1310

SPAT

Counselling related to known health issue

1.4

44.2

2324

17658

Z51.80

ICD-10 Finland

Manipulation of puberty development with hormone therapy

71.9

44.0

N06AX22

ATC

agomelatine; oral

2.7

43.9

242

915

JN4AD

NOMESCO Finland

Body CT examination

1.7

43.8

789

4698

A10AB05

ATC

insulin aspart; parenteral

1.9

43.8

599

3281

E29.9

ICD-10 Finland

Testicular dysfunction, unspecified

8.0

43.8

J02AC01

ATC

fluconazole; systemic

1.4

43.6

2919

23126

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

43.6

536

2835

WX723

NOMESCO Finland

CPAP therapy

2.2

43.5

388

1822

N05BA12

ATC

alprazolam; oral

1.8

43.5

737

4311

-50

ICPC

Medication/prescr/renewal

2.4

43.5

312

1337

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

43.5

336

1488

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

43.4

2219

16762

A28

ICPC

Limited function/disability NOS

1.6

43.0

1104

7211

SPAT1229

SPAT

Assessment of need for aid

2.0

42.9

502

2609

A04

ICPC

Weakness/tiredness general

1.6

42.9

1265

8536

C08CA13

ATC

lercanidipine; oral

1.7

42.8

937

5883

M05BX04

ATC

denosumab; parenteral

2.1

42.7

422

2063

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

3.7

42.5

136

373

A11CC03

ATC

alfacalcidol; systemic

2.8

42.5

212

761

M79.7

ICD-10 Finland

Fibromyalgia

2.4

42.4

309

1334

R96

ICPC

Asthma

1.7

42.4

763

4542

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

42.1

807

4889

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

42.0

2096

15744

ZY010

NOMESCO Finland

Hospital outpatient

2.0

41.9

503

2637

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

41.9

312

1360

Z2446

NOMESCO Finland

Social worker

1.9

41.7

596

3309

A12AA04

ATC

calcium carbonate; oral

3.4

41.7

148

435

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

4.4

41.6

104

238

N05AF03

ATC

chlorprothixene; systemic

2.7

41.5

234

895

N03AX14

ATC

levetiracetam; systemic

2.5

41.4

262

1060

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

41.4

434

2169

SPAT1216

SPAT

Assessment of functional ability

1.6

41.2

980

6279

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

41.2

263

1069

BC1CD

NOMESCO Finland

Very extensive CT of adrenal glands

7.7

41.1

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

7.7

41.1

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

41.0

487

2544

R01AD08

ATC

fluticasone; nasal

1.4

40.9

2175

16512

A12BA01

ATC

potassium chloride; oral

2.5

40.9

257

1037

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

40.7

402

1965

C10AC01

ATC

colestyramine; oral

2.6

40.7

235

910

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

40.5

262

1071

L04AX01

ATC

azathioprine; systemic

2.2

40.5

371

1761

E86

ICD-10 Finland

Volume depletion

2.9

40.5

198

703

N02BF01

ATC

gabapentin; oral

1.7

40.5

793

4829

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

40.1

457

2352

J45

ICD-10 Finland

Asthma

1.7

40.0

832

5147

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.3

40.0

315

1406

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.0

39.9

427

2150

ZXA10

NOMESCO Finland

Bilateral

1.5

39.8

1261

8633

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

39.7

667

3888

P76

ICPC

Depressive disorder

1.8

39.6

599

3384

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

39.6

335

1540

2535A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Diabetes insipidus

+∞

39.6

Q96.9

ICD-10 Finland

Turner syndrome, unspecified

+∞

39.6

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.6

39.5

239

946

R35

ICD-10 Finland

Polyuria

1.9

39.5

495

2634

E28.3

ICD-10 Finland

Primary ovarian failure

6.5

39.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

39.2

1498

10667

R03BA01

ATC

beclometasone; inhalant

1.6

39.1

983

6380

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

38.9

331

1525

H02AB07

ATC

prednisone; oral

1.6

38.9

925

5922

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

38.7

613

3511

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

38.7

484

2573

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.9

38.7

189

671

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

38.6

162

528

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

38.6

306

1370

A10AE04

ATC

insulin glargine; parenteral

1.8

38.4

674

3978

N91.4

ICD-10 Finland

Secondary oligomenorrhoea

5.6

38.3

129

B01AB05

ATC

enoxaparin; parenteral

1.4

38.2

2086

15877

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

38.2

197

720

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

38.1

513

2793

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

38.1

440

2275

E23.1

ICD-10 Finland

Drug-induced hypopituitarism

378.9

38.0

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

6.2

38.0

103

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.4

37.8

273

1173

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

37.8

648

3798

N06AX03

ATC

mianserin; oral

2.2

37.8

347

1648

WX892

NOMESCO Finland

Monitored bed care

1.8

37.7

550

3072

R06AE07

ATC

cetirizine; oral

1.4

37.7

3390

27979

C07AB02

ATC

metoprolol; systemic

1.5

37.6

1177

8030

R4190

NOMESCO Finland

Nutritional therapy

2.0

37.5

417

2127

R03DC01

ATC

zafirlukast; oral

3.4

37.5

136

405

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

37.4

388

1931

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

37.4

859

5450

N05CF02

ATC

zolpidem; oral

1.5

37.3

1258

8720

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

3.6

37.3

125

354

Z71.8

ICD-10 Finland

Other specified counselling

1.4

37.2

2706

21593

JN4BD

NOMESCO Finland

Extensive body CT

1.7

36.9

659

3908

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

36.8

440

2302

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.5

36.8

241

991

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.8

36.7

192

707

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

36.7

2457

19333

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

36.7

2200

16996

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.9

36.6

168

E24.3

ICD-10 Finland

Ectopic ACTH syndrome

+∞

36.5

8370/3-C74.0

ICD-O-3

Adrenal cortical carcinoma of cortex of adrenal gland

+∞

36.5

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

5.5

36.4

128

M48.0

ICD-10 Finland

Spinal stenosis

1.7

36.3

753

4650

R63.1

ICD-10 Finland

Polydipsia

6.9

36.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

36.3

1991

15142

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

6.4

36.1

A01AB09

ATC

miconazole; local oral

1.8

36.0

589

3406

E23.3

ICD-10 Finland

Hypothalamic dysfunction, not elsewhere classified

358.6

36.0

205

Kela drug reimbursment

Chronic hypertension

1.5

35.7

1477

10663

OAB50, ,

SPAT

1.8

35.6

587

3401

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

35.6

603

3523

D75.1

ICD-10 Finland

Secondary polycythaemia

5.0

35.5

153

2530A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Acromegaly and gigantism[ACROMEGALIA]

+∞

35.4

25320

ICD-8 Finland

Diseases of pituitary gland, Chromophobe adenoma, pituitary

+∞

35.4

L01XX23

ATC

mitotane; oral

+∞

35.4

9350/1-C75.2

ICD-O-3

Craniopharyngioma, NOS, of craniopharyngeal duct

+∞

35.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

35.3

634

3764

J01DA01

ATC

[U] cefalexin

1.3

35.2

4510

39069

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.6

35.1

214

851

ZXE00

NOMESCO Finland

One hour or less

1.4

35.1

2825

22849

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.0

35.0

153

511

8700/3-C74.1

ICD-O-3

Pheochromocytoma, NOS, of medulla of adrenal gland

348.4

34.9

R01AD09

ATC

mometasone; nasal

1.3

34.9

3500

29248

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

34.9

871

5635

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

34.9

1356

9666

A10BJ02

ATC

liraglutide; parenteral

2.4

34.8

236

986

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

34.8

328

1575

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

34.6

251

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

34.6

673

4085

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

34.6

247

1057

Z3226

NOMESCO Finland

Physiotherapist

1.5

34.6

1318

9356

Z31.5

ICD-10 Finland

Genetic counselling

1.9

34.6

470

2567

C09CA06

ATC

candesartan; oral

1.4

34.5

1696

12632

SPAT1312

SPAT

General health counselling

1.4

34.5

2363

18620

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

34.5

439

2346

N05AB03

ATC

perphenazine; systemic, rectal

2.2

34.4

280

1267

L17

ICPC

Foot/toe symptom/complaint

1.4

34.4

2262

17708

F34.1

ICD-10 Finland

Dysthymia

2.2

34.4

313

1482

25390

ICD-8 Finland

Diseases of pituitary gland, Diabetes insipidus

+∞

34.4

106

Kela drug reimbursment

Hypoparathyroidism

6.6

34.3

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

34.3

496

2763

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

34.2

1173

8147

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

34.0

357

1784

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

34.0

634

3804

2370A

ICD-9 Finland

Neoplasm of uncertain behaviour of endocrine glands and nervous system, Pituitary gland and craniopharyngeal duct

338.3

33.9

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.4

33.9

240

1023

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.5

33.9

212

854

N06AA10

ATC

nortriptyline; systemic

2.7

33.8

181

675

UDC00

NOMESCO Finland

Ear microscopy

1.8

33.7

552

3191

J01FA06

ATC

roxithromycin; oral

1.4

33.6

2741

22173

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

33.4

3154

26070

2554A

ICD-9 Finland

Disorders of adrenal glands, Corticoadrenal insufficiency[MORBUS ADDISON PRIMARIUS]

+∞

33.3

Z2445

NOMESCO Finland

Psychologist

2.0

33.3

385

1991

M01AH01

ATC

celecoxib; oral

1.5

33.3

1150

7997

RD210, ,

NOMESCO Finland

2.6

33.2

202

803

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.4

33.1

119

353

P03

ICPC

Feeling depressed

1.6

33.1

878

5760

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

33.1

337

1666

R4110, ,

SPAT

1.6

32.9

927

6164

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

32.9

437

2368

N91.2

ICD-10 Finland

Amenorrhoea, unspecified

4.8

32.8

156

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.7

32.8

710

4432

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.7

32.8

184

703

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

32.8

661

4050

A01

ICPC

Pain general/multiple sites

1.6

32.7

739

4661

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

32.6

207

839

S10

ICPC

Boil/carbuncle

1.9

32.6

457

2519

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.0

32.5

143

479

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

32.5

412

2199

WX002

NOMESCO Finland

Sedation and analgesia

1.5

32.5

1262

8983

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

32.4

175

655

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

32.4

450

2473

2532A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Panhypopituitarism[PANHYPOPITUITARISMUS]

+∞

32.3

J01AA02

ATC

doxycycline; systemic

1.3

32.1

5731

51727

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

32.0

317

1551

L03

ICPC

Low back symptom/complaint

1.4

32.0

2201

17319

XKD00

NOMESCO Finland

Uroflowmetry

1.6

31.9

891

5910

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.0

31.6

138

461

R52.9

ICD-10 Finland

Pain, unspecified

1.6

31.5

774

4984

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

31.3

456

2545

Q96.3

ICD-10 Finland

Mosaicism, 45,X/46,XX or XY

+∞

31.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

31.2

2856

23435

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.4

31.1

111

328

A04AA01

ATC

ondansetron; systemic, rectal

1.7

31.1

595

3594

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

31.0

1327

9613

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.9

31.0

149

525

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.4

30.9

111

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

30.9

1934

14975

XLA10, ,

NOMESCO Finland

2.0

30.9

332

1674

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

30.8

851

5629

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

30.8

1065

7399

R03BA02

ATC

budesonide; inhalant

1.5

30.7

1306

9448

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

30.7

790

5140

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

30.7

801

5231

8700/3-C74.9

ICD-O-3

Pheochromocytoma, NOS, of adrenal gland, NOS

160.4

30.7

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

30.6

904

6071

Z00.0

ICD-10 Finland

General medical examination

1.4

30.6

1398

10250

L04AA06

ATC

mycophenolic acid; systemic

2.6

30.6

181

710

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

30.6

250

1134

R03AC13

ATC

formoterol; inhalant

2.0

30.5

344

1764

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

30.5

137

465

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

30.5

902

6061

WVA20, ,

SPAT

2.1

30.2

294

1429

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.5

30.2

196

804

N04BC01

ATC

bromocriptine; oral

58.5

30.1

A03FA02

ATC

cisapride; oral, rectal

1.8

30.0

461

2614

M03BX02

ATC

tizanidine; oral

1.3

30.0

4626

40700

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

29.8

143

503

SPAT1325

SPAT

Vaccination

1.3

29.8

2248

17898

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

29.6

856

5718

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

29.5

964

6613

J01FA09

ATC

clarithromycin; systemic

1.3

29.4

2269

18120

J01FA10

ATC

azithromycin; systemic

1.3

29.4

4494

39442

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

29.3

170

660

P01

ICPC

Feeling anxious/nervous/tense

1.5

29.3

1124

7966

I15.2

ICD-10 Finland

Hypertension secondary to endocrine disorders

8.6

29.2

25800

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Cushing's syndrome

+∞

29.2

T82

ICPC

Obesity

1.9

29.2

354

1862

N06AA12

ATC

doxepin; systemic

2.0

29.1

329

1688

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

29.1

500

2929

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

29.0

937

6413

F61.0

ICD-10 Finland

Mixed personality disorders

2.7

29.0

156

584

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

29.0

574

3498

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

28.9

2006

15761

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

28.9

148

540

R06.5

ICD-10 Finland

Mouth breathing

1.6

28.9

694

4442

H53.2

ICD-10 Finland

Diplopia

2.2

28.8

244

1124

E27

ICD-10 Finland

Other disorders of adrenal gland

150.4

28.6

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

28.6

297

1479

R01AD01

ATC

beclometasone; nasal

1.5

28.5

1058

7449

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.8

28.4

147

539

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

28.4

130

446

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

28.4

290

1435

A10BJ06

ATC

semaglutide; parenteral

1.9

28.4

385

2100

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

28.3

724

4703

A10AC01

ATC

insulin (human); parenteral

1.7

28.2

500

2956

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.4

28.1

290

M25.5

ICD-10 Finland

Pain in joint

1.3

28.1

2477

20143

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

28.1

456

2629

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

28.0

1814

14084

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

28.0

352

1874

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

28.0

1020

7154

S06.0

ICD-10 Finland

Concussion

1.5

27.9

821

5506

G03GA01

ATC

chorionic gonadotrophin; parenteral

2.1

27.8

279

1371

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

27.8

475

2778

A10BH01

ATC

sitagliptin; oral

1.7

27.8

566

3474

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

27.6

670

4295

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

27.6

333

1747

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

27.6

1937

15224

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.9

27.6

337

1776

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.6

27.6

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

27.5

553

3381

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

27.5

378

2070

J01EA01

ATC

trimethoprim; systemic

1.4

27.5

1699

13088

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

27.5

117

385

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

27.5

337

1778

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

27.5

1605

12254

R33

ICD-10 Finland

Retention of urine

1.8

27.5

460

2675

SPAT1255

SPAT

Intravenous administration of medicine

1.8

27.5

447

2578

N03AF01

ATC

carbamazepine; oral, rectal

1.9

27.4

326

1703

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

27.3

340

1803

P29

ICPC

Psychological sympt/compl other

1.6

27.3

661

4237

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

27.3

163

643

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.5

27.2

165

656

P06

ICPC

Sleep disturbance

1.5

27.2

997

6999

25399

ICD-8 Finland

Diseases of pituitary gland, Other and unspecified

+∞

27.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

27.0

2219

17843

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.4

27.0

195

840

K59.0

ICD-10 Finland

Constipation

1.8

26.8

393

2197

AA400

NOMESCO Finland

Electroconvulsive therapy

3.8

26.8

219

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

26.6

1001

7060

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

26.6

274

1361

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

26.6

432

2491

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

26.4

222

1019

M79.1

ICD-10 Finland

Myalgia

1.4

26.4

1113

8022

R52.1

ICD-10 Finland

Chronic intractable pain

3.4

26.4

273

R03AC03

ATC

terbutaline; inhalant

1.5

26.4

957

6701

E000001, ,

ATC

1.4

26.4

1409

10592

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

26.3

162

649

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

3.1

26.2

108

349

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

26.2

362

1986

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

26.2

675

4390

C08CA02

ATC

felodipine; oral

1.7

26.1

525

3212

25398

ICD-8 Finland

Diseases of pituitary gland, Alii definiti

+∞

26.0

127

Kela drug reimbursment

Transplant complication

2.6

26.0

147

564

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

25.9

710

4683

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

25.8

290

1485

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.4

25.8

179

757

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

25.8

316

1668

SAA04

NOMESCO Finland

Special examination of mouth

1.8

25.7

426

2471

R03BB01

ATC

ipratropium bromide; inhalant

2.2

25.6

215

987

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.6

25.6

147

569

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

25.5

317

1680

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.4

25.4

265

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

25.4

1318

9852

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

25.4

495

3002

C02AC05

ATC

moxonidine; oral

2.0

25.3

285

1461

SPAT1234

SPAT

Support of social functional capacity

1.9

25.3

320

1707

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

25.3

391

2222

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.4

25.2

179

765

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

25.2

389

2209

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

25.2

730

4875

C09CA01

ATC

losartan; oral

1.4

25.1

1577

12159

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

25.1

518

3189

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

25.1

191

842

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

25.0

251

1234

E25.8

ICD-10 Finland

Other adrenogenital disorders

+∞

25.0

25500

ICD-8 Finland

Diseases of adrenal glands, Aldosteronismus. Syndroma Conn

+∞

25.0

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

24.9

346

1902

N03AF02

ATC

oxcarbazepine; oral

2.0

24.7

260

1301

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

24.7

191

847

Y99

ICPC

Genital disease male other

5.9

24.7

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

24.7

501

3070

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

24.6

225

1068

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

24.6

2068

16643

A01AB04

ATC

amphotericin B; local oral

2.0

24.6

271

1379

R01AD12

ATC

fluticasone furoate; nasal

1.3

24.6

2420

19902

A02BA04

ATC

nizatidine; systemic

1.7

24.6

436

2577

M05BA07

ATC

risedronic acid; oral

2.4

24.6

173

737

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

24.5

368

2072

C10AA05

ATC

atorvastatin; oral

1.3

24.5

2556

21180

U04

ICPC

Incontinence urine

1.8

24.5

363

2036

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.5

24.5

153

617

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

24.4

1543

11905

G43.3

ICD-10 Finland

Complicated migraine

2.5

24.3

159

655

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.5

24.3

155

631

N04AA02

ATC

biperiden; systemic

2.6

24.3

145

572

Z01.2

ICD-10 Finland

Dental examination

1.3

24.3

3712

32251

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

3.6

24.3

220

C01CA24

ATC

epinephrine; parenteral

1.7

24.3

490

2999

N30.0

ICD-10 Finland

Acute cystitis

1.4

24.1

1194

8845

L04AA01

ATC

[U] ciclosporin

2.9

24.1

110

377

D07AC01

ATC

betamethasone; topical

1.3

24.1

2524

20913

R5599

NOMESCO Finland

Other rehabilitation service

2.2

24.1

215

1011

N05AH02

ATC

clozapine; systemic

2.4

24.1

158

652

N06AX18

ATC

reboxetine; oral

3.1

24.0

315

25310

ICD-8 Finland

Diseases of pituitary gland, Panhypopituitarismus

+∞

24.0

2270A

ICD-9 Finland

Benign neoplasm of other endocrine glands and related structures, Adrenal gland

+∞

24.0

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.9

23.9

181

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

3.9

23.9

177

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.9

23.8

282

1471

J05AB01

ATC

aciclovir; systemic

1.4

23.8

1497

11533

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.4

23.8

167

711

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

23.7

717

4828

J01CA04

ATC

amoxicillin; systemic

1.3

23.7

6542

61060

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

23.6

631

4136

P99

ICPC

Psychological disorders other

2.0

23.6

261

1331

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

23.5

1554

12061

F83

ICD-10 Finland

Mixed specific developmental disorders

3.2

23.5

284

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

23.4

219

1049

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

23.4

639

4208

A07AA09

ATC

vancomycin; oral

2.8

23.4

113

400

602

Kela drug reimbursment

Children's severe malnutrition

3.7

23.3

198

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

23.3

495

3068

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

23.3

2542

21155

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.1

23.2

229

1119

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.7

23.2

194

XF404

NOMESCO Finland

Ambulatory ECG

1.6

23.2

538

3408

L68.0

ICD-10 Finland

Hirsutism

3.9

23.2

176

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

23.2

1076

7876

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

4.2

23.2

150

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

23.2

1540

11958

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

23.2

4220

37348

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

23.2

490

3035

R06AE09

ATC

levocetirizine; oral

1.4

23.1

1044

7606

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

23.1

5412

49337

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.6

23.1

218

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.4

23.1

162

689

SPAT1211

SPAT

Application of soft bandage

1.6

23.1

593

3850

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

23.1

250

1265

Y08

ICPC

Sexual function sympt/compl male

4.7

23.0

110

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

23.0

112

398

G93.2

ICD-10 Finland

Benign intracranial hypertension

5.9

23.0

A10AE05

ATC

insulin detemir; parenteral

1.8

23.0

371

2135

A29

ICPC

General symptom/complaint other

1.5

23.0

908

6456

25300

ICD-8 Finland

Diseases of pituitary gland, Aeromegalia

+∞

22.9

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

22.9

247

1248

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

22.8

759

5214

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.8

22.8

114

411

N04BC05

ATC

pramipexole; oral

1.7

22.8

468

2876

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.5

22.8

145

590

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

22.8

3460

29958

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.9

22.8

300

1622

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

22.8

817

5700

N06AB08

ATC

fluvoxamine; oral

2.2

22.7

188

859

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

22.6

218

1057

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.1

22.5

215

1038

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

22.5

106

370

S21

ICPC

Skin texture symptom/complaint

1.4

22.5

1042

7625

ZY000

NOMESCO Finland

Hospital inpatient

2.7

22.5

123

465

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

22.5

563

3634

G04CA01

ATC

alfuzosin; oral

1.5

22.4

672

4517

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

22.4

1718

13621

R07.3

ICD-10 Finland

Other chest pain

1.5

22.3

699

4742

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

22.3

266

1392

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

22.2

184

840

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

22.2

309

1699

L04AD01

ATC

ciclosporin; systemic

2.4

22.2

155

658

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.5

22.2

142

580

D07AA02

ATC

hydrocortisone; topical

1.4

22.1

1034

7576

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

22.1

181

823

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.7

22.1

110

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

22.1

407

2431

N48.4

ICD-10 Finland

Impotence of organic origin

2.2

22.0

176

792

TGC00

NOMESCO Finland

Bronchial lavation

2.3

22.0

170

754

R41.0

ICD-10 Finland

Disorientation, unspecified

2.2

22.0

183

837

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

22.0

1601

12590

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

7.6

22.0

R01AD05

ATC

budesonide; nasal

1.6

22.0

495

3115

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.0

21.9

247

1267

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

21.9

924

6647

Q96.8

ICD-10 Finland

Other variants of Turner syndrome

+∞

21.9

BCA41

NOMESCO Finland

Endoscopic bilateral adrenalectomy

+∞

21.9

2550A

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SDR CUSHING E HYPERPLASIA GLANDULAE SUPRARENALI]

+∞

21.9

E22.88

ICD-10 Finland

Other hyperfunction of pituitary gland

+∞

21.9

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

21.9

156

669

SPAT1252

SPAT

Overall medication plan or its review

1.7

21.9

381

2241

A99

ICPC

Disease/condition unspecnature/site

1.5

21.8

718

4921

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

21.8

375

2197

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

21.8

4141

36724

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

21.7

405

2426

C08DA01

ATC

verapamil; systemic

2.0

21.7

252

1306

R13

ICD-10 Finland

Dysphagia

1.6

21.6

457

2829

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.6

21.6

120

457

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

21.6

2000

16257

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

21.6

822

5798

T55

ICPC

Metabolic, Local injection/infiltration

7.1

21.6

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.0

21.5

320

R4110

NOMESCO Finland

Physiotherapy

1.3

21.5

1888

15236

R04

ICPC

Breathing problem other

1.9

21.5

283

1529

J47

ICD-10 Finland

Bronchiectasis

2.6

21.5

119

453

M01AE02

ATC

naproxen; oral, rectal

1.2

21.5

4238

37714

C08CA05

ATC

nifedipine; systemic

1.8

21.5

345

1983

A10BK03

ATC

empagliflozin; oral

1.5

21.4

622

4151

M01AH02

ATC

rofecoxib; oral

1.5

21.4

714

4906

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

21.4

162

713

XG466

NOMESCO Finland

Sleep oxymetry

2.1

21.4

201

966

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

21.3

231

1169

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

21.3

118

449

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

21.2

5712

52626

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

21.2

1217

9224

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

21.1

1461

11398

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

21.1

481

3035

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

21.0

749

5215

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.0

21.0

314

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

21.0

569

3740

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

21.0

100

352

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

20.9

713

4922

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.4

20.9

139

578

R60.1

ICD-10 Finland

Generalized oedema

3.6

20.9

190

JAH01

NOMESCO Finland

Laparoscopy

1.8

20.9

322

1829

E89.39

ICD-10 Finland

Postprocedural hypopituitarism, other or several procedures

+∞

20.8

D352, E221,

ICD-10 Finland

+∞

20.8

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

20.8

720

4984

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.4

20.8

224

H26.3

ICD-10 Finland

Drug-induced cataract

3.8

20.8

163

R4180

NOMESCO Finland

Podiatric therapy

2.8

20.8

100

354

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

7.1

20.7

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

20.7

186

878

C10AA01

ATC

simvastatin; oral

1.3

20.6

2236

18532

WX730

NOMESCO Finland

Conventional respirator

2.6

20.6

115

440

SPAT1097

SPAT

Recording of ECG

1.4

20.5

831

5930

Y50

ICPC

Male Genital, Medication/prescr/renewal

8.2

20.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

20.3

199

971

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

7.5

20.3

N06AX05

ATC

trazodone; oral

2.1

20.3

184

872

E83.50

ICD-10 Finland

Hypercalcemia

2.8

20.3

353

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

20.3

326

N05AE04

ATC

ziprasidone; systemic

3.5

20.2

194

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.5

20.2

121

479

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

20.2

267

1446

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

20.2

282

1554

N05AF01

ATC

flupentixol; systemic

2.7

20.2

109

410

Z00.8

ICD-10 Finland

Other general examinations

1.5

20.1

568

3766

C09AA02

ATC

enalapril; systemic

1.4

20.1

1041

7756

K02.1

ICD-10 Finland

Caries of dentine

1.2

20.0

4620

41680

UJD02

NOMESCO Finland

Gastroscopy

1.8

20.0

296

1660

WZC00, ,

SPAT

1.4

20.0

1084

8137

I95.9

ICD-10 Finland

Hypotension, unspecified

2.7

20.0

109

412

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.1

20.0

G04CA02

ATC

tamsulosin; oral

1.4

19.9

1204

9199

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

19.8

427

2656

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

19.8

168

775

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

19.8

266

1447

N19

ICD-10 Finland

Unspecified kidney failure

2.0

19.8

208

1041

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

19.8

439

2750

-1, ,

NOMESCO Finland

1.3

19.8

2506

21139

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

19.8

218

1110

SFA10

NOMESCO Finland

One-surface restoration

1.2

19.8

4218

37706

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

19.8

321

1850

Q96

ICD-10 Finland

Turner syndrome

+∞

19.8

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

19.7

1648

13190

A10BK01

ATC

dapagliflozin; oral

1.6

19.7

480

3077

R5110, ,

SPAT

1.6

19.7

522

3413

N05AD01

ATC

haloperidol; systemic

2.1

19.7

188

909

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

19.7

244

1294

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.8

19.6

311

1780

E83.51

ICD-10 Finland

Hypocalcemia

3.8

19.6

156

V03AE01

ATC

polystyrene sulfonate; oral

2.9

19.6

305

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

19.6

489

3153

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

19.6

329

1916

E31.00

ICD-10 Finland

APECED syndrome

200.3

19.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.9

19.5

234

1227

A08

ICPC

Swelling

1.7

19.5

352

2090

M02AA07

ATC

piroxicam; topical

1.3

19.4

2177

18091

H57.1

ICD-10 Finland

Ocular pain

1.8

19.4

303

1728

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.5

19.4

123

501

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

3.8

19.4

153

F31

ICD-10 Finland

Bipolar affective disorder

2.6

19.3

110

425

Y0099

ICD-8 Finland

Investigation of endocrine system and metabolism

4.4

19.3

106

WYA10

NOMESCO Finland

Emergency care or similar visit

1.6

19.3

526

3462

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

19.2

182

877

ZXA05

NOMESCO Finland

Left side

1.3

19.2

1453

11469

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.6

19.1

112

439

N29

ICPC

Neurological sympt/complt other

2.3

19.1

141

615

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.0

1812

14746

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

19.0

548

3650

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.2

19.0

156

711

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.0

19.0

204

1031

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.2

18.9

156

712

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

18.9

108

418

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

18.9

386

2370

H05.2

ICD-10 Finland

Exophthalmic conditions

6.2

18.9

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

6.2

18.9

E000003, ,

ATC

1.8

18.8

299

1713

S55

ICPC

Skin, Local injection/infiltration

4.6

18.8

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

18.8

1992

16428

R01AD58

ATC

fluticasone, combinations; nasal

1.3

18.8

1890

15486

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.8

18.8

284

1604

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.6

18.8

175

AA4DM

NOMESCO Finland

Very extensive MRI examination of sella turcica with 3 Tesla magnet

+∞

18.7

2550X

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING NUD]

+∞

18.7

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

18.7

265

WX290

NOMESCO Finland

Other blockage of nerve

1.2

18.7

3694

32675

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

8.1

18.7

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

18.7

434

2750

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.1

18.7

172

820

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1.9

18.7

249

1352

N91.0

ICD-10 Finland

Primary amenorrhoea

6.5

18.7

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

18.7

276

IHZ05, ,

SPAT

1.7

18.7

372

2269

L86

ICPC

Back syndrome with radiating pain

1.6

18.6

416

2612

OAB42

NOMESCO Finland

Guidance related to known health problem

4.6

18.6

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

18.6

1005

7536

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.2

18.6

154

705

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

18.5

434

2756

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

18.5

388

2397

A07DA03

ATC

loperamide; oral

2.0

18.5

194

971

J01CF05

ATC

flucloxacillin; systemic

1.6

18.5

504

3315

-55

ICPC

Local injection/infiltration

3.8

18.5

149

L29

ICPC

Musculoskeletal sympt/complt other

1.5

18.5

602

4115

D11

ICPC

Diarrhoea

1.4

18.5

917

6779

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

18.4

313

1828

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

18.4

377

2315

N17

ICPC

Vertigo/dizziness

1.4

18.4

816

5914

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

18.4

157

727

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

3.9

18.4

136

RJ410, ,

NOMESCO Finland

4.7

18.4

OAB72

NOMESCO Finland

Weight control and weight loss guidance

2.8

18.4

311

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.4

18.4

192

G91.1

ICD-10 Finland

Obstructive hydrocephalus

4.6

18.4

N97.9

ICD-10 Finland

Female infertility, unspecified

1.7

18.4

343

2057

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

18.3

393

2442

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

18.3

1007

7568

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.2

18.3

160

748

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

18.3

523

3477

N06AA06

ATC

trimipramine; systemic

2.1

18.3

163

768

K76.9

ICD-10 Finland

Liver disease, unspecified

2.6

18.3

105

408

L95

ICPC

Osteoporosis

1.9

18.2

222

1171

A02BX02

ATC

sucralfate; oral

1.9

18.2

220

1157

R04.0

ICD-10 Finland

Epistaxis

1.6

18.2

444

2847

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

18.2

196

991

E30.09

ICD-10 Finland

Delayed puberty NOS

7.4

18.2

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

7.4

18.2

120

Kela drug reimbursment

Hypogammaglobulinaemia

5.9

18.2

N06AA04

ATC

clomipramine; systemic

2.5

18.2

117

480

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.5

18.2

179

R51

ICD-10 Finland

Headache

1.6

18.2

428

2723

SFA30

NOMESCO Finland

Three-surface restoration

1.2

18.1

2962

25651

J01DA06

ATC

[U] cefuroxime

1.4

18.1

902

6669

C03AA03

ATC

hydrochlorothiazide; oral

1.6

18.1

464

3010

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.1

18.1

181

891

C07AG02

ATC

carvedilol; oral

1.7

18.1

310

1816

R06AX22

ATC

ebastine; oral

1.3

18.1

1170

9020

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.3

18.0

134

586

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

18.0

250

1376

D02AE01

ATC

carbamide; topical

1.6

18.0

412

2603

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

4.9

18.0

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

18.0

370

2277

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

17.9

168

807

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

17.9

169

814

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

17.9

443

2851

WX213

NOMESCO Finland

Lower leg blockade

3.1

17.9

246

E03

ICD-10 Finland

Other hypothyroidism

1.6

17.9

393

2458

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

17.9

512

3406

C09AA05

ATC

ramipril; oral

1.3

17.9

1341

10561

SPAT1139

SPAT

Nutrition survey

1.9

17.8

212

1110

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.2

17.8

149

685

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.2

17.8

211

TK800

NOMESCO Finland

Hemodialysis

2.2

17.7

145

660

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

17.7

316

1872

WX308

NOMESCO Finland

Sacral anesthesy

4.4

17.7

XF402

NOMESCO Finland

ECG with work load test

1.5

17.7

582

3987

AN1

Coronary angiography

1.5

17.6

528

3545

Z02.7

ICD-10 Finland

Issue of medical certificate

1.5

17.6

507

3375

B01AC04

ATC

clopidogrel; oral

1.4

17.6

837

6139

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

17.6

405

2561

XF602

NOMESCO Finland

Bloodpressure monitoring

2.7

17.6

352

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

17.6

151

701

E000002, ,

ATC

1.4

17.6

754

5433

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

17.5

364

XQ800

NOMESCO Finland

Prick test

1.5

17.5

548

3713

L04AX03

ATC

methotrexate; systemic

1.5

17.5

646

4524

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

3.7

17.5

150

A03

ICPC

Fever

1.3

17.5

1391

11036

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.2

17.5

218

C10AA07

ATC

rosuvastatin; oral

1.3

17.5

2111

17655

AA4AD

NOMESCO Finland

CT of sella turcica

180.2

17.5

N46

ICD-10 Finland

Male infertility

2.5

17.5

104

411

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

17.5

906

11945

AAK40

NOMESCO Finland

Closure of cerebrospinal fluid fistula

15.6

17.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

17.4

348

2125

BF20A, ,

NOMESCO Finland

28.8

17.4

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

17.3

964

7256

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

4.2

17.3

107

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.7

17.3

290

1688

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

17.3

402

2550

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

17.3

181

907

M81.8

ICD-10 Finland

Other osteoporosis

3.0

17.3

246

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.6

17.2

385

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.1

17.2

162

781

N02AJ13

ATC

tramadol and paracetamol; systemic

2.1

17.1

157

748

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.3

17.1

127

555

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.6

17.1

357

G04BD12

ATC

mirabegron; oral

1.4

17.1

665

4706

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

17.1

1084

8328

ZXA00

NOMESCO Finland

Right side

1.3

17.1

1547

12489

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

4.3

17.0

100

K07.60

ICD-10 Finland

Snapping jaw

1.6

17.0

374

2340

J32.4

ICD-10 Finland

Chronic pansinusitis

2.4

17.0

114

477

R05

ICD-10 Finland

Cough

1.3

16.9

1503

12098

M03BX01

ATC

baclofen; systemic

2.2

16.9

141

647

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

16.9

427

2760

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

16.9

476

3154

SPAT1243

SPAT

Psychiatric/psychological examination

1.9

16.9

211

1123

WX722

NOMESCO Finland

PEEP

1.7

16.9

279

1618

N06AX17

ATC

milnacipran; oral

2.8

16.8

293

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

6.1

16.8

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.0

16.8

171

848

EB1VA, ,

NOMESCO Finland

1.3

16.8

1267

9979

R62.0

ICD-10 Finland

Delayed milestone

2.9

16.8

277

S29

ICPC

Skin symptom/complaint other

1.3

16.8

1388

11070

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

5.6

16.7

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

5.6

16.7

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.2

16.7

199

SPAT1360

SPAT

Extensive global examination

1.6

16.7

412

2650

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

16.7

496

3326

UJF92

NOMESCO Finland

Capsular endoscopy

2.0

16.7

168

830

2550B

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERFUNCTIO GLAN SUPRARENALI]

+∞

16.7

2533A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Pituitary dwarfism[NANISMUS HYPOPHYSARIUS]

+∞

16.7

Q96.4

ICD-10 Finland

Mosaicism, 45,X/other cell line(s) with abnormal sex chromosome

+∞

16.7

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.7

16.7

328

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

3.1

16.6

225

A06AC51

ATC

ispaghula, combinations; oral

1.7

16.6

291

1715

E66.0

ICD-10 Finland

Obesity due to excess calories

3.0

16.6

252

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

16.6

199

1046

NHQ40

NOMESCO Finland

Amputation of toe

2.6

16.5

352

RD211, ,

NOMESCO Finland

1.8

16.5

266

1531

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.3

16.5

119

514

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.9

16.5

274

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.9

16.5

220

1196

SFA20

NOMESCO Finland

Two-surface restoration

1.2

16.5

4430

40215

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

16.5

280

1637

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

16.5

698

5017

A02BB01

ATC

misoprostol; oral

4.1

16.5

107

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

1.9

16.5

218

1183

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.6

16.4

401

2572

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

5.5

16.4

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

16.4

249

1409

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.9

16.4

208

1113

G03GA02

ATC

human menopausal gonadotrophin; parenteral

2.0

16.4

168

836

J02AC02

ATC

itraconazole; systemic

1.3

16.3

1108

8591

D07AC13

ATC

mometasone; topical

1.3

16.3

1903

15832

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.3

16.3

126

561

H47.1

ICD-10 Finland

Papilloedema, unspecified

3.5

16.3

153

R94.7

ICD-10 Finland

Abnormal results of other endocrine function studies

12.1

16.3

T86

ICPC

Hypothyroidism/myxoedema

1.7

16.2

293

1742

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

16.2

221

1210

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

16.2

519

3536

F05.9

ICD-10 Finland

Delirium, unspecified

2.3

16.2

122

538

P01BA02

ATC

hydroxychloroquine; oral

1.5

16.1

503

3408

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

3.9

16.1

122

E26.9

ICD-10 Finland

Hyperaldosteronism, unspecified

7.1

16.1

DPA30

NOMESCO Finland

Sphenotomy

3.3

16.0

174

A10AB04

ATC

insulin lispro; parenteral

1.8

16.0

219

1200

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

16.0

2543

21882

G72.8

ICD-10 Finland

Other specified myopathies

2.5

16.0

100

405

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

16.0

497

3363

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

16.0

445

2941

H26.2

ICD-10 Finland

Complicated cataract

2.6

16.0

335

K03.66

ICD-10 Finland

Tooth plaque

1.5

16.0

588

4116

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.1

16.0

151

729

N75

ICPC

Benign neoplasm nervous system

13.5

15.9

K30

ICD-10 Finland

Functional dyspepsia

1.4

15.9

760

5579

SPAT1053

SPAT

Memory test

1.4

15.9

637

4533

U05

ICPC

Urination problems other

1.7

15.9

312

1898

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

15.8

515

3518

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

15.8

244

1387

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

15.8

329

2030

X58

ICD-10 Finland

Exposure to other specified factors

1.3

15.8

1076

8345

F41.00

ICD-10 Finland

Moderate panic disorder

2.2

15.8

130

594

SCA02

NOMESCO Finland

Preventive oral health care

1.4

15.8

870

6537

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

15.8

375

2392

B37.08

ICD-10 Finland

Other candidal stomatitis

3.0

15.7

238

EBA00

NOMESCO Finland

Extraction of tooth

1.2

15.7

2668

23109

N05AA01

ATC

chlorpromazine; systemic, rectal

2.6

15.7

344

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

15.7

360

2276

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.0

15.7

175

897

25599

ICD-8 Finland

Diseases of adrenal glands, Other and unspecified

+∞

15.6

E25.0

ICD-10 Finland

Congenital adrenogenital disorders associated with enzyme deficiency

+∞

15.6

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

15.6

347

2177

N92.2

ICD-10 Finland

Excessive menstruation at puberty

4.5

15.6

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

15.6

261

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

15.6

336

2093

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

15.6

286

1709

E24

ICD-10 Finland

Cushing syndrome

85.2

15.5

A11CC02

ATC

dihydrotachysterol; oral

6.0

15.5

C10AX09

ATC

ezetimibe; oral

1.3

15.5

984

7552

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.8

15.5

237

1344

R06AX13

ATC

loratadine; oral

1.3

15.5

1016

7836

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

15.5

1535

12517

L01

ICPC

Neck symptom/complaint

1.3

15.5

1143

8968

R4120

NOMESCO Finland

Occupational therapy

1.5

15.4

438

2909

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

15.4

166

841

N05AF05

ATC

zuclopenthixol; systemic

2.9

15.4

241

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.9

15.4

252

J01DC02

ATC

cefuroxime; systemic

1.6

15.4

359

2280

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.3

15.4

179

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

1.9

15.3

179

932

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

15.3

290

1747

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

15.3

321

1987

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

15.3

1141

8966

E66

ICD-10 Finland

Obesity

1.6

15.2

403

2634

F45.0

ICD-10 Finland

Somatization disorder

3.7

15.2

127

J01FA15

ATC

telithromycin; oral

1.4

15.2

613

4364

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

3.3

15.2

175

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.5

15.2

385

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

15.2

747

5507

A41.8

ICD-10 Finland

Other specified sepsis

2.3

15.2

115

508

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.5

15.2

146

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

15.2

698

5088

F32

ICD-10 Finland

Depressive episode

1.6

15.2

387

2509

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

15.2

786

5846

N01

ICPC

Headache

1.3

15.1

921

7023

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

15.1

879

6658

Z08

ICPC

Social welfare problem

2.4

15.1

101

423

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

15.0

1249

9953

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

15.0

1787

14884

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

15.0

278

1666

J01DA09

ATC

[U] cefadroxil

1.3

15.0

1718

14248

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.8

15.0

208

1147

49300

ICD-8 Finland

Asthma, bronchiale

2.1

14.9

144

701

IGY02, ,

SPAT

2.1

14.9

132

622

B03XA02

ATC

darbepoetin alfa; parenteral

2.2

14.9

130

609

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.9

14.9

180

949

SBB10

NOMESCO Finland

Dental impressions

1.4

14.9

581

4113

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

14.9

2238

19120

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.9

14.8

196

1064

M01AH05

ATC

etoricoxib; oral

1.2

14.8

4472

40857

B81

ICPC

Anaemia vit B12/folate deficiency

1.8

14.8

208

1151

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

5.9

14.7

SPAT1377

SPAT

Polysomnography

1.8

14.7

207

1145

RS222, ,

NOMESCO Finland

2.5

14.7

367

B01AA03

ATC

warfarin; systemic

1.3

14.7

913

6983

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

4.4

14.7

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

14.7

309

1914

A02BC04

ATC

rabeprazole; oral

1.4

14.6

561

3957

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

14.6

138

666

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

6.1

14.6

R06AX27

ATC

desloratadine; oral

1.2

14.6

2170

18506

D35.9

ICD-10 Finland

Benign neoplasm: Endocrine gland, unspecified

21.0

14.6

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

2.3

14.6

105

454

6116A

ICD-9 Finland

Other disorders of breast, Galactorrhoea not associated with childbirth

+∞

14.6

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

14.5

183

978

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.3

14.5

105

455

Z56.5

ICD-10 Finland

Uncongenial work

6.3

14.5

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.1

14.5

131

622

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

14.5

231

1327

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.4

14.5

689

5050

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.0

14.5

153

770

K08.80

ICD-10 Finland

Toothache NOS

1.4

14.5

631

4556

J20

ICD-10 Finland

Acute bronchitis

1.4

14.5

694

5094

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

2.9

14.4

239

N05AL01

ATC

sulpiride; systemic

2.4

14.4

389

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

14.4

1463

11954

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

3.7

14.4

123

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

14.3

886

6771

R68.2

ICD-10 Finland

Dry mouth, unspecified

3.1

14.3

187

A07EA06

ATC

budesonide; oral, local oral

1.7

14.3

251

1483

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

14.2

456

3106

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

14.2

275

1667

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

14.2

115

523

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

14.2

135

654

T89

ICPC

Diabetes insulin dependent

1.6

14.2

289

1775

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

14.2

2868

25208

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

14.1

1291

10409

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

14.1

179

959

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

2.8

14.1

253

R52.0

ICD-10 Finland

Acute pain

1.7

14.1

236

1375

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

14.1

118

544

-69

ICPC

Other reason for encounter NEC

1.8

14.1

220

1257

B80

ICPC

Iron deficiency anaemia

1.9

14.1

179

960

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

14.1

316

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.2

14.1

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.8

14.1

204

1140

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.7

14.0

459

6564

R25.1

ICD-10 Finland

Tremor, unspecified

1.9

14.0

187

1018

J01CA08

ATC

pivmecillinam; oral

1.2

14.0

2656

23192

C01DA14

ATC

isosorbide mononitrate; oral

1.4

14.0

693

5112

3051, ,

Kela drug reimbursment

2.5

14.0

358

WW200

NOMESCO Finland

Immunization

1.8

14.0

188

1026

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.7

14.0

229

1326

RS221, ,

NOMESCO Finland

2.2

14.0

112

507

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

3.7

14.0

116

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

14.0

120

559

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

14.0

274

1667

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

2.9

14.0

211

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

3.5

13.9

135

B02.9

ICD-10 Finland

Zoster without complication

1.5

13.9

397

2639

W19

ICD-10 Finland

Unspecified fall

1.4

13.9

643

4691

N02AC04

ATC

dextropropoxyphene; oral

1.9

13.8

175

937

RS220, ,

NOMESCO Finland

2.3

13.8

104

459

N05AX15

ATC

cariprazine; oral

3.5

13.8

136

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

13.8

393

2612

M01AB55

ATC

diclofenac, combinations; oral

1.6

13.8

346

2236

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

2.5

13.8

361

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.8

13.8

229

G62.8

ICD-10 Finland

Other specified polyneuropathies

2.8

13.8

240

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.1

13.7

124

589

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

13.7

1980

16817

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

13.7

839

10827

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

13.7

436

2966

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

13.7

177

955

F60.5

ICD-10 Finland

Anankastic personality disorder

2.4

13.6

381

K08.3

ICD-10 Finland

Retained dental root

1.5

13.6

476

3299

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.6

13.6

304

IFC01, ,

SPAT

5.1

13.6

KFH00

NOMESCO Finland

Operation for undescended or ectopic testis

5.1

13.6

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

4.2

13.6

B02AA02

ATC

tranexamic acid; systemic

1.3

13.5

925

7170

3028

Kela drug reimbursment

Mepolizumab

12.0

13.5

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.9

13.5

176

951

7586A

ICD-9 Finland

Chromosomal anomalies, Gonadal dysgenesis

+∞

13.5

25508

ICD-8 Finland

Diseases of adrenal glands, Hyperfunctio adrenocorticalis alia

+∞

13.5

AA4BM

NOMESCO Finland

MRI examination of sella turcica with 3 Tesla magnet

+∞

13.5

AA4BD

NOMESCO Finland

Extensive CT of sella turcica

+∞

13.5

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.8

13.5

105

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

3.8

13.5

105

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

13.5

324

2071

OAB43, ,

SPAT

0.8

13.5

1922

22416

L01BA01

ATC

methotrexate; systemic

1.7

13.5

219

1265

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.0

13.5

143

721

T50

ICPC

Metabolic, Medication/prescr/renewal

4.4

13.5

K06.18

ICD-10 Finland

Another gingival hyperplasia

3.6

13.5

119

NF1DA

NOMESCO Finland

X-ray of hips

2.1

13.5

129

627

AA1AA

NOMESCO Finland

Head X-ray examination

2.9

13.5

210

B01AB04

ATC

dalteparin; parenteral

1.6

13.4

293

1831

9500/3-C74.1

ICD-O-3

Neuroblastoma, NOS, of medulla of adrenal gland

140.1

13.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

13.4

183

1004

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

13.4

600

4352

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.7

13.4

249

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

13.4

185

1019

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

13.4

630

4609

L14

ICPC

Leg/thigh symptom/complaint

1.4

13.4

519

3669

N62

ICD-10 Finland

Hypertrophy of breast

1.7

13.4

263

1602

R15

ICD-10 Finland

Faecal incontinence

1.9

13.3

160

842

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

13.3

290

1811

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

13.3

187

1035

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

13.3

831

6357

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

5.6

13.3

R05

ICPC

Cough

1.2

13.3

1751

14718

137

Kela drug reimbursment

Uraemia requiring dialysis

2.7

13.3

250

D35.59

ICD-10 Finland

Other paragangliom

21.1

13.3

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.4

13.3

349

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

13.3

407

2748

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

13.3

111

512

N03AX18

ATC

lacosamide; systemic

2.7

13.3

256

M04AA01

ATC

allopurinol; systemic

1.4

13.2

657

4850

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

4.1

13.2

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.0

13.2

135

672

N03AB02

ATC

phenytoin; systemic

2.7

13.2

251

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

13.2

277

1715

N25.1

ICD-10 Finland

Nephrogenic diabetes insipidus

13.8

13.2

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

13.2

333

2155

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

3.9

13.2

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

2.5

13.2

309

M54.2

ICD-10 Finland

Cervicalgia

1.4

13.2

538

3841

M02AA10

ATC

ketoprofen; topical

1.3

13.1

945

7377

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

2.6

13.1

286

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.5

13.1

350

2294

F60.8

ICD-10 Finland

Other specific personality disorders

2.9

13.1

208

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

13.1

482

3376

E30.8

ICD-10 Finland

Other disorders of puberty

12.1

13.1

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.0

13.1

187

N06BA04

ATC

methylphenidate; oral

1.6

13.0

318

2042

A27

ICPC

Fear of other disease NOS

1.6

13.0

309

1971

A10BG03

ATC

pioglitazone; oral

2.0

13.0

134

669

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

5.9

13.0

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.7

13.0

244

1468

GX2D5

NOMESCO Finland

Sleep oximetry

3.0

13.0

193

H47.4

ICD-10 Finland

Disorders of optic chiasm

28.4

12.9

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

12.9

427

2927

183

Kela drug reimbursment

Lamotrigin and topiramate

2.5

12.9

300

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

12.9

206

1185

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

3.6

12.9

118

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

12.9

107

492

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.1

12.9

119

571

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

1.8

12.9

172

938

A10BJ05

ATC

dulaglutide; parenteral

2.1

12.8

121

585

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

12.8

205

P20

ICPC

Memory disturbance

1.4

12.8

662

4918

IHZ04, ,

SPAT

2.0

12.8

137

694

Q53.1

ICD-10 Finland

Undescended testicle, unilateral

4.4

12.8

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

4.4

12.8

L60.0

ICD-10 Finland

Ingrowing nail

1.6

12.8

323

2091

B03XA01

ATC

erythropoietin; parenteral

2.8

12.8

222

297, ,

Kela drug reimbursment

11.5

12.8

40199

ICD-8 Finland

Essential benign hypertension

2.4

12.7

350

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

12.7

323

2093

SPAT1058

SPAT

PEF monitoring instruction

1.5

12.7

468

3276

L13

ICPC

Hip symptom/complaint

1.3

12.7

1146

9214

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.9

12.7

206

F50.0

ICD-10 Finland

Anorexia nervosa

2.8

12.7

228

7834C

ICD-9 Finland

Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[HÄIRIINTYNYT PITUUSKASVU]

14.0

12.7

R31

ICD-10 Finland

Unspecified haematuria

1.4

12.7

542

3899

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.1

12.7

123

601

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

3.2

12.7

159

SPAT1281

SPAT

Other administrative function

1.4

12.7

490

3463

G03DA02

ATC

medroxyprogesterone; systemic

1.5

12.7

444

3080

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.0

12.7

129

642

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

3.8

12.7

101

F61

ICD-10 Finland

Mixed and other personality disorders

3.6

12.6

115

J05AB11

ATC

valaciclovir; oral

1.3

12.6

924

7229

R06.4

ICD-10 Finland

Hyperventilation

2.2

12.6

106

490

A10AE06

ATC

insulin degludec; parenteral

1.7

12.6

231

1381

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.7

12.6

237

1427

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.3

12.6

433

L15

ICPC

Knee symptom/complaint

1.2

12.6

1663

13976

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

2.9

12.6

202

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

3.8

12.6

J01MA01

ATC

ofloxacin; systemic

1.5

12.6

440

3052

R1250, ,

SPAT

1.7

12.6

206

1195

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.6

12.5

287

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

2.0

12.5

132

665

D01

ICPC

Abdominal pain/cramps general

1.3

12.5

889

6926

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

2.5

12.5

293

ICB06, ,

NOMESCO Finland

2.4

12.5

353

R30.0

ICD-10 Finland

Dysuria

1.6

12.5

296

1888

E24.4

ICD-10 Finland

Alcohol-induced pseudo-Cushing syndrome

+∞

12.5

25311

ICD-8 Finland

Diseases of pituitary gland, Hypopituitarismus partialis

+∞

12.5

M14.5*E22.0

ICD-10 Finland

Arthropathy associated with acromegaly

+∞

12.5

2559X

ICD-9 Finland

Disorders of adrenal glands, Unspecified disorder of adrenal glands

+∞

12.5

H02AB02

ATC

dexamethasone; systemic

1.4

12.5

652

4852

A12AA06

ATC

calcium lactate gluconate; oral

11.0

12.5

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

12.5

163

883

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

12.5

147

770

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

12.5

135

687

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

12.4

374

2515

A10BH05

ATC

linagliptin; oral

1.6

12.4

252

1547

D35.3

ICD-10 Finland

Benign neoplasm: Craniopharyngeal duct

130.1

12.4

XKC03

NOMESCO Finland

Water cystometry

1.8

12.4

168

920

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

12.4

905

7076

M01AE51

ATC

ibuprofen, combinations; systemic

2.3

12.4

404

N18.0

ICD-10 Finland

End-stage renal disease

2.7

12.4

248

-1, ,

ICPC

1.7

12.4

219

1297

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

12.4

388

2632

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.0

12.4

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.0

12.4

128

641

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.0

12.3

122

601

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

12.3

217

1284

Z01.7

ICD-10 Finland

Laboratory examination

1.3

12.3

1124

9051

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

12.3

614

4536

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1.9

12.3

141

732

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

12.3

1621

13617

R03BC03

ATC

nedocromil; inhalant

1.5

12.3

380

2572

C05AA08

ATC

fluocortolone; rectal, topical

1.3

12.3

792

6088

D07AD01

ATC

clobetasol; topical

1.3

12.3

1037

8270

N05CD02

ATC

nitrazepam; oral

2.3

12.3

375

E000006, ,

ATC

1.5

12.2

397

2712

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.6

12.2

267

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

2.7

12.2

233

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

12.2

345

2290

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

12.2

220

1311

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

12.2

782

6006

WW500

NOMESCO Finland

Blood transfusion

1.7

12.2

232

1403

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

3.7

12.1

104

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

12.1

469

3315

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.3

12.1

138

SPAT1167

SPAT

Insertion of urinary catheter

1.9

12.1

148

785

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.7

12.1

200

1163

-44

ICPC

Preventive immunization/medic

1.5

12.1

442

3091

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

4.7

12.1

R89.1

ICD-10 Finland

Abnormal findings in specimens from other organs, systems and tissues, abnormal level of hormones

12.4

12.1

S04

ICPC

Lump/swelling localized

1.3

12.1

733

5584

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

3.7

12.0

100

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

3.7

12.0

100

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

4.1

12.0

R03DX09

ATC

mepolizumab; parenteral

11.0

12.0

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

2.8

12.0

202

L12

ICPC

Hand/finger symptom/complaint

1.3

12.0

1210

9862

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.0

12.0

170

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.4

11.9

324

D01AE15

ATC

terbinafine; topical

1.5

11.9

401

2759

M35.7

ICD-10 Finland

Hypermobility syndrome

2.1

11.9

110

528

G04BD07

ATC

tolterodine; oral

1.7

11.9

233

1418

R4120, ,

SPAT

2.2

11.9

424

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.3

11.9

374

P74

ICPC

Anxiety disorder/anxiety state

1.5

11.9

345

2304

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.0

11.9

133

685

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

1.9

11.9

137

713

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

4.4

11.9

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

11.9

414

2870

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

4.8

11.9

TKC22

NOMESCO Finland

Catheterisation instruction

2.0

11.9

127

644

P73

ICPC

Affective psychosis

3.4

11.9

125

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

11.8

279

1778

R49.08

ICD-10 Finland

Other specified dysphonia

1.9

11.8

138

721

XX4AW, ,

NOMESCO Finland

3.1

11.8

156

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

11.8

1177

9581

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

4.1

11.7

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

3.1

11.7

151

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.4

11.7

121

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.4

11.7

659

4961

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.5

11.7

285

C07AB12

ATC

nebivolol; oral

1.8

11.7

172

967

R09

ICPC

Sinus symptom/complaint

1.4

11.7

556

4075

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

11.7

140

738

I50.0

ICD-10 Finland

Congestive heart failure

1.5

11.7

323

2135

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.6

11.7

107

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.6

11.6

304

1984

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

11.6

464

3298

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.1

11.6

108

520

D07AB08

ATC

desonide; topical

1.3

11.6

687

5212

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

5.5

11.6

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.3

11.6

378

M01AX17

ATC

nimesulide; oral

1.2

11.6

1309

10802

R00.2

ICD-10 Finland

Palpitations

1.4

11.6

523

3799

D35.50

ICD-10 Finland

Carotid body

65.0

11.6

BC5AQ

NOMESCO Finland

Chromaffine tissue SPECT with low dose CT

65.0

11.6

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

1.8

11.6

172

970

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

11.6

557

4090

S50

ICPC

Skin, Medication/prescr/renewal

2.9

11.6

184

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

11.6

105

501

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

11.6

329

2188

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

11.6

240

H50.31

ICD-10 Finland

Intermittent exotropia

2.5

11.6

275

SPAT1251

SPAT

Organisation of medication

1.8

11.5

183

1052

B01AB10

ATC

tinzaparin; parenteral

1.4

11.5

637

4782

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.7

11.5

185

1067

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

11.5

113

555

N28

ICPC

Limited function/disability (N)

2.1

11.5

107

515

K04.0

ICD-10 Finland

Pulpitis

1.4

11.5

633

4750

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.6

11.5

232

1424

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

3.1

11.5

153

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

11.5

118

590

L29.9

ICD-10 Finland

Pruritus, unspecified

1.8

11.5

178

1017

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.2

11.5

457

J96.1

ICD-10 Finland

Chronic respiratory failure

2.1

11.5

111

543

25598

ICD-8 Finland

Diseases of adrenal glands, Alii definiti

+∞

11.5

E22

ICD-10 Finland

Hyperfunction of pituitary gland

+∞

11.5

H01AX01

ATC

pegvisomant; parenteral

+∞

11.5

25319

ICD-8 Finland

Diseases of pituitary gland, Hypopituitarismus alia sive NUD

+∞

11.5

25502

ICD-8 Finland

Diseases of adrenal glands, Virilismus adrenocorticalis

+∞

11.5

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.3

11.4

709

5416

5BA08, ,

NOMESCO Finland

3.3

11.4

123

WF099

NOMESCO Finland

Other radiotherapy

3.3

11.4

128

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

3.2

11.4

133

DHB50

NOMESCO Finland

Turbinoplasty

1.8

11.4

172

974

L16

ICPC

Ankle symptom/complaint

1.3

11.4

833

6512

BC5AN

NOMESCO Finland

Chromaffine and adrenergic tissue isotope imaging (MIBG)

120.1

11.4

E89.31

ICD-10 Finland

Postirradiation hypopituitarism

120.1

11.4

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

11.4

781

6052

PA2AD

NOMESCO Finland

CT angiography of brain

2.5

11.4

265

N02CC04

ATC

rizatriptan; oral

1.5

11.4

363

2472

C08DB01

ATC

diltiazem; oral

1.7

11.4

221

1343

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

2.4

11.4

307

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

2.3

11.4

375

188

Kela drug reimbursment

Psychosis requiring demanding treatment

2.5

11.4

289

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.6

11.4

250

1568

S06

ICPC

Rash localized

1.5

11.3

337

2262

K92.1

ICD-10 Finland

Melaena

1.6

11.3

281

1813

SPAT1125

SPAT

Stoma care and guidance

2.3

11.3

357

P80

ICPC

Personality disorder

3.1

11.3

144

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.5

11.3

290

2397A

ICD-9 Finland

Neoplasm of unspecified nature, Endocrine glands and other parts of nervous system

15.0

11.3

WGA11

NOMESCO Finland

Planning of pain management

3.0

11.3

160

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

11.3

460

3284

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.2

11.3

415

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

11.3

1164

9508

S51.8

ICD-10 Finland

Open wound of other parts of forearm

2.3

11.3

358

WX872

NOMESCO Finland

Intensive care

1.6

11.2

271

1737

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.3

11.2

377

N05AX16

ATC

brexpiprazole; oral

3.5

11.2

105

D09

ICPC

Nausea

1.5

11.2

352

2389

F22.0

ICD-10 Finland

Delusional disorder

2.2

11.2

409

X78

ICD-10 Finland

Intentional self-harm by sharp object

2.8

11.2

193

G44.0

ICD-10 Finland

Cluster headache syndrome

2.3

11.2

365

F40.2

ICD-10 Finland

Specific (isolated) phobias

2.6

11.2

244

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.0

11.2

123

630

H65.3

ICD-10 Finland

Chronic mucoid otitis media

1.7

11.2

183

1062

U02

ICPC

Urinary frequency/urgency

1.3

11.2

913

7245

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.0

11.2

118

596

M54.3

ICD-10 Finland

Sciatica

1.5

11.2

361

2466

Y29

ICPC

Genital symptom/complaint male other

2.8

11.2

199

S76

ICPC

Skin infection other

1.5

11.2

326

2181

D06

ICPC

Abdominal pain localized other

1.4

11.1

608

4556

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.0

11.1

115

576

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.7

11.1

216

L08

ICPC

Shoulder symptom/complaint

1.2

11.1

1481

12438

B01AF02

ATC

apixaban; oral

1.3

11.1

663

5036

J01FA01

ATC

erythromycin; systemic

1.3

11.1

885

6999

BC1BD

NOMESCO Finland

Extensive CT of adrenal glands

12.7

11.1

G04BD11

ATC

fesoterodine; oral

1.9

11.1

140

751

WVA20

NOMESCO Finland

Medicine administration

1.8

11.1

175

1005

N07BC02

ATC

methadone; systemic

3.5

11.1

106

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.7

11.1

178

1028

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.5

11.1

269

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.5

11.1

281

M05BA01

ATC

etidronic acid; systemic

3.9

11.1

RJ421, ,

NOMESCO Finland

3.9

11.1

G72.9

ICD-10 Finland

Myopathy, unspecified

2.7

11.0

217

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.2

11.0

412

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

5.2

11.0

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.8

11.0

175

1007

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

11.0

112

558

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

11.0

505

3679

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.7

11.0

223

M86.6

ICD-10 Finland

Other chronic osteomyelitis

3.9

11.0

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

11.0

156

869

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

3.5

11.0

102

9109

FHL

Other measure in this category

5.0

11.0

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

11.0

394

N07CA01

ATC

betahistine; oral

1.5

11.0

379

2624

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

3.5

10.9

107

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

10.9

116

587

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.0

10.9

163

SPAT1104

SPAT

Monitoring of emergency patient

1.5

10.9

362

2485

Z50.1

ICD-10 Finland

Other physical therapy

1.5

10.9

296

1949

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

3.4

10.9

112

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

10.9

587

4391

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.0

10.9

116

588

D01AC02

ATC

miconazole; topical

1.4

10.9

411

2894

S01

ICPC

Pain/tenderness of skin

1.5

10.9

291

1911

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.6

10.9

242

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

3.0

10.9

153

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

10.9

178

1034

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.0

10.8

106

521

R04.2

ICD-10 Finland

Haemoptysis

1.7

10.8

183

1072

Z2221

NOMESCO Finland

Medical doctor

1.2

10.8

1782

15286

AA4WT

NOMESCO Finland

Selective blood sample from sinus petrosus inferior

15.5

10.8

J01MA06

ATC

norfloxacin; oral

1.3

10.8

712

5488

-56

ICPC

Dressing/pressure/compress/tamponade

2.1

10.8

442

H01

ICPC

Ear pain/earache

1.3

10.8

871

6900

N05AE03

ATC

sertindole; oral

3.9

10.8

L52

ICD-10 Finland

Erythema nodosum

2.8

10.8

186

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

10.8

111

556

R81

ICPC

Pneumonia

1.6

10.8

225

1394

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

1.9

10.8

122

632

K07

ICPC

Swollen ankles/oedema

1.6

10.7

243

1535

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

3.6

10.7

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

10.7

238

1496

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

10.5

10.7

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

10.7

2589

22976

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.8

10.7

169

971

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.7

10.7

188

1113

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

10.7

244

1544

R51.81

ICD-10 Finland

Facial pain NOS

1.8

10.7

154

861

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.7

10.7

198

N18

ICPC

Paralysis/weakness

2.0

10.7

109

544

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

10.7

321

2161

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.0

10.7

111

558

M01AX01

ATC

nabumetone; oral

1.6

10.7

219

1351

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

10.7

811

6375

H26.02

ICD-10 Finland

Presenil cataract

1.8

10.7

152

848

F40.1

ICD-10 Finland

Social phobias

1.7

10.6

195

1168

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

10.6

665

5086

B07.9

ICD-10 Finland

Verruca simplex

1.6

10.6

258

1657

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.8

10.6

150

834

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

10.6

192

1146

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.0

10.6

106

525

BF10A, ,

NOMESCO Finland

60.0

10.6

E31.08

ICD-10 Finland

Autoimmune polyglandular failure

60.0

10.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

1.8

10.6

143

784

R06.2

ICD-10 Finland

Wheezing

1.5

10.6

298

1978

J30.3

ICD-10 Finland

Other allergic rhinitis

1.6

10.6

250

1596

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.2

10.6

368

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

4.1

10.6

5604

FHL

Vascular preparation or cannulation in the operating room

5.3

10.6

L04AD02

ATC

tacrolimus; systemic

2.2

10.5

407

A97

ICPC

No disease

1.2

10.5

1358

11360

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

1.8

10.5

162

924

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

10.5

339

2314

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.7

10.5

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.0

10.5

117

602

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.0

10.5

117

602

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

2.9

10.5

172

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.0

10.5

156

M17.4

ICD-10 Finland

Other secondary gonarthrosis, bilateral

3.4

10.5

110

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

4.3

10.5

QDB10, ,

SPAT

1.8

10.4

148

824

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.9

10.4

123

646

C75.1

ICD-10 Finland

Malignant neoplasm: Pituitary gland

110.1

10.4

AA4CD

NOMESCO Finland

Very extensive CT of sella turcica

+∞

10.4

9350/1-C75.1

ICD-O-3

Craniopharyngioma, NOS, of pituitary gland

+∞

10.4

Q96.2

ICD-10 Finland

Karyotype 46,X with abnormal sex chromosome, except iso (Xq)

+∞

10.4

25810

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction

+∞

10.4

L02AE02

ATC

leuprorelin; implant, parenteral

1.6

10.4

231

1453

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

10.4

196

1183

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.1

10.4

469

XG405

NOMESCO Finland

Education on PEF monitoring

2.1

10.4

423

X57

ICD-10 Finland

Unspecified privation

1.8

10.4

143

790

L04AA13

ATC

[U] leflunomide

1.8

10.4

143

790

SPAT1131

SPAT

Colonoscopy

1.7

10.3

164

945

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.3

10.3

334

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.8

10.3

147

821

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.1

10.3

438

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

10.3

126

671

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

10.6

10.2

2159

FHL

Other measure in this category

18.8

10.2

L26

ICD-10 Finland

Exfoliative dermatitis

4.9

10.2

BC00A, ,

NOMESCO Finland

9.5

10.2

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

10.2

286

1897

E87.2

ICD-10 Finland

Acidosis

3.3

10.2

112

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

10.2

115

595

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.9

10.2

115

595

NF1DA, ,

SPAT

4.0

10.2

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.4

10.2

274

M03AX01

ATC

botulinum toxin; parenteral

2.0

10.2

486

R29

ICPC

Respiratory symptom/complaint other

1.4

10.2

432

3108

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

10.1

511

3782

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

2.9

10.1

154

ZX112

NOMESCO Finland

Subcutaneous

1.9

10.1

128

688

MAX99

NOMESCO Finland

Assistance to normal delivery

0.7

10.1

258

3874

M54.1

ICD-10 Finland

Radiculopathy

1.6

10.1

237

1511

P28

ICPC

Limited function/disability (P)

2.4

10.1

269

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

10.1

388

2741

WX704

NOMESCO Finland

Intubation

1.4

10.1

495

3648

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

10.1

447

3239

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.2

10.1

363

NG1DA

NOMESCO Finland

X-ray of knees

2.0

10.1

104

522

S22.3

ICD-10 Finland

Fracture of rib

1.4

10.0

419

3004

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

3.0

10.0

139

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.8

10.0

137

755

F80.1

ICD-10 Finland

Expressive language disorder

2.3

10.0

332

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

5.0

10.0

62600

ICD-8 Finland

Disorders of menstruation, Absent

4.3

10.0

BBA20

NOMESCO Finland

Exploration of parathyroid gland

4.3

10.0

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.9

10.0

119

627

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

10.0

615

4693

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

3.9

10.0

N05BA02

ATC

chlordiazepoxide; systemic

1.9

10.0

128

691

P72

ICPC

Schizophrenia

1.9

10.0

127

684

G04BD08

ATC

solifenacin; oral

1.5

10.0

319

2176

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.4

10.0

493

3638

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

2.2

10.0

371

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

1.9

10.0

118

621

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.7

10.0

162

940

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

2.9

10.0

161

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

9.9

159

918

TPH00

NOMESCO Finland

Phlebotomy

3.2

9.9

119

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

2.5

9.9

241

N05BA09

ATC

clobazam; oral

2.5

9.9

247

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

3.7

9.9

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

3.7

9.9

C10AA03

ATC

pravastatin; oral

1.5

9.9

333

2293

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

9.9

677

5243

R86.1

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of hormones

4.0

9.9

Z50.5

ICD-10 Finland

Speech therapy

1.9

9.9

112

580

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.1

9.9

411

RS142, ,

NOMESCO Finland

3.8

9.9

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.9

9.9

111

574

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

9.9

159

920

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

2.9

9.9

151

F59

ICD-10 Finland

Unspecified behavioural syndromes associated with physiological disturbances and physical factors

4.1

9.9

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

9.9

733

5744

N05AB04

ATC

prochlorperazine; systemic, rectal

2.0

9.8

109

561

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.8

9.8

142

796

OAB72, ,

SPAT

1.9

9.8

115

603

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

9.8

286

1914

XQ820

NOMESCO Finland

Exposure to medicinal substance

3.2

9.8

120

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

4.2

9.8

Q53.2

ICD-10 Finland

Undescended testicle, bilateral

8.1

9.8

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

9.8

228

1452

C02DE02, ,

ATC

2.5

9.8

237

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

9.8

112

583

N05AC02

ATC

thioridazine; oral

1.9

9.8

114

597

OAB93, ,

SPAT

1.4

9.8

493

3650

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

3.0

9.8

136

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

9.7

381

E66.1

ICD-10 Finland

Drug-induced obesity

3.8

9.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.1

9.7

454

H05BX01

ATC

cinacalcet; oral

2.9

9.7

147

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.7

9.7

160

932

WX610

NOMESCO Finland

Patient controlled analgesia

2.6

9.7

197

F84.5

ICD-10 Finland

Asperger syndrome

2.4

9.7

256

6BA02, ,

NOMESCO Finland

3.4

9.7

D12

ICPC

Constipation

1.6

9.7

211

1322

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

2.9

9.7

158

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.8

9.7

131

720

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

3.4

9.7

101

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

9.7

229

1464

E21.2

ICD-10 Finland

Other hyperparathyroidism

3.7

9.7

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

9.7

260

1711

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

9.6

136

757

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

9.6

145

823

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.4

9.6

257

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.1

9.6

436

SPAT1172

SPAT

Guidance concerning hydration

2.0

9.6

105

538

M01AB05

ATC

diclofenac; systemic, rectal

1.2

9.6

4594

42866

S06.3

ICD-10 Finland

Focal brain injury

2.3

9.6

313

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.4

9.6

356

2500

D84.18

ICD-10 Finland

Other specified defect in the complement system

7.8

9.6

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.0

9.6

457

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.1

9.6

437

XA402

NOMESCO Finland

ENMG

1.8

9.5

147

840

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

1.8

9.5

138

774

H81.3

ICD-10 Finland

Other peripheral vertigo

1.7

9.5

152

877

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

9.5

130

716

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

9.5

238

1540

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

2.6

9.5

199

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

9.5

289

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

4.4

9.5

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.8

9.5

138

775

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

3.6

9.5

B37.0

ICD-10 Finland

Candidal stomatitis

2.3

9.5

321

F48.0

ICD-10 Finland

Neurasthenia

4.0

9.5

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.7

9.5

176

1060

ZZH40

NOMESCO Finland

Substitute of bone

2.5

9.5

229

S22

ICPC

Nail symptom/complaint

1.4

9.5

409

2952

XX2RW, ,

NOMESCO Finland

2.1

9.4

419

XF640, ,

NOMESCO Finland

1.8

9.4

132

733

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

9.4

166

N05BB01

ATC

hydroxyzine; systemic

1.4

9.4

347

2433

M82.1

ICD-10 Finland

Osteoporosis in endocrine disorders

100.1

9.4

N06AA22, ,

ATC

3.0

9.4

139

M89.0

ICD-10 Finland

Algoneurodystrophy

2.4

9.4

272

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.0

9.4

494

XX9XW, ,

NOMESCO Finland

2.6

9.4

212

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

9.4

121

655

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

9.4

1342

11337

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

9.4

202

1263

2550C

ICD-9 Finland

Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERSECRETIO HYPOFYSEOS]

+∞

9.4

2552A

ICD-9 Finland

Disorders of adrenal glands, Adrenogenital disorders[SYNDROMA ADRENOGENITALE CONGENITUM]

+∞

9.4

2538X

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin[MORBUS HYPOPHYSEOS SEU HYPOTHALAMI ALIA]

+∞

9.4

D352, E220,

ICD-10 Finland

+∞

9.4

E89.32

ICD-10 Finland

Hypopituitarism after medical therapy

+∞

9.4

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

9.4

2253

19943

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

9.3

190

1171

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

5.1

9.3

ZYY01

NOMESCO Finland

Contact between professionals

2.8

9.3

167

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.4

9.3

421

3062

JF1AD

NOMESCO Finland

Small bowel CT

2.6

9.3

190

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

1.7

9.3

170

1020

K11.2

ICD-10 Finland

Sialoadenitis

1.6

9.3

205

1290

J96.9

ICD-10 Finland

Respiratory failure, unspecified

2.7

9.3

179

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.2

9.3

318

SXC05

NOMESCO Finland

Other oral or dental procedure

1.3

9.3

532

4020

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.0

9.2

504

SBA00

NOMESCO Finland

Microbiological examinations

1.7

9.2

161

953

F33

ICD-10 Finland

Recurrent depressive disorder

1.7

9.2

166

991

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

9.2

127

702

160

Kela drug reimbursment

exenatide

1.9

9.2

105

546

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

1.9

9.2

106

553

ICB01, ,

SPAT

2.3

9.2

306

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.7

9.2

174

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

3.8

9.2

R08

ICPC

Nose symptom/complaint other

1.6

9.2

229

1482

U29

ICPC

Urinary symptom/complaint other

1.7

9.2

172

1038

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

2.8

9.2

163

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

9.2

183

1123

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.0

9.2

451

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.0

9.2

451

G40.10

ICD-10 Finland

Simple partial seizures

2.7

9.2

180

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.1

9.1

115

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

2.9

9.1

136

G44.8

ICD-10 Finland

Other specified headache syndromes

1.9

9.1

110

583

D72.1

ICD-10 Finland

Eosinophilia

3.3

9.1

100

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

3.2

9.1

105

NXL00

NOMESCO Finland

Biopsy of muscle

3.2

9.1

105

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

2.6

9.1

192

B34.9

ICD-10 Finland

Viral infection, unspecified

1.6

9.1

217

1390

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.6

9.1

198

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

4.3

9.1

R5120

NOMESCO Finland

Preparation of an aid

1.7

9.1

150

875

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.7

9.1

239

3564

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

2.8

9.1

153

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

2.5

9.1

216

SGA01

NOMESCO Finland

Emergency treatment

1.2

9.1

1116

9283

E20.8

ICD-10 Finland

Other hypoparathyroidism

11.4

9.0

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

9.0

230

1496

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

9.0

397

2874

D01AE16

ATC

amorolfine; topical

1.3

9.0

622

4824

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

3.1

9.0

116

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

2.2

9.0

309

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

3.4

9.0

C09CA03

ATC

valsartan; oral

1.4

9.0

477

3560

R4140

NOMESCO Finland

Psychotherapy

2.7

9.0

176

JAH00

NOMESCO Finland

Laparotomy

1.7

9.0

149

870

NGQ20

NOMESCO Finland

Amputation of lower leg

3.2

9.0

106

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.5

9.0

315

2189

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

2.5

9.0

211

RS110, ,

NOMESCO Finland

3.6

9.0

R49.01

ICD-10 Finland

Functional dysphonia

1.7

8.9

171

1038

N07BB01

ATC

disulfiram; oral

1.5

8.9

263

1765

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

2.3

8.9

291

M10.9

ICD-10 Finland

Gout, unspecified

1.4

8.9

345

2441

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3003181) Sodium [Moles/volume] in Urine

637

1213

5.60

319.12

1.9

1.5

73.59

63.36

mmol/l

5.24

556

980

(3020911) Cortisol [Moles/time] in 24 hour Urine

306

242

13.08

316.63

2.3

1.2

528.26

99.73

nmol/24h

2.04

306

242

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1482

2622

6.65

307.65

3.3

1.7

34.02

40.54

nmol/l

14.75

1435

2563

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2225

486

62.04

307.65

3.2

2.1

19.05

21.38

nmol/l

4.46

2158

465

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1296

1937

7.73

307.65

3.3

1.8

176.07

207.68

pmol/l

14.58

1255

1837

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1635

4787

4.00

307.65

3.5

4.39

4.55

pmol/l

7.67

1517

4326

(3035637) Corticotropin [Mass/volume] in Plasma

1631

889

22.55

307.65

2.4

1.3

58.03

23.06

ng/l

13.73

1619

889

(3023323) Follitropin [Units/volume] in Serum or Plasma

1780

4671

4.57

307.65

2.0

1.4

17.44

25.38

iu/l

21.69

1448

3898

(3011985) Renin [Units/volume] in Plasma

775

986

8.55

307.65

3.5

1.3

75.48

68.40

mu/l

0.28

730

881

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

872

1381

6.93

307.65

1.9

1.4

0.27

0.42

nmol/l

5.28

630

1076

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

492

70.52

307.65

2.0

1.2

1.21

0.81

nmol/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4925

31139

2.42

307.65

10.8

7.2

1.21

mmol/l

1.75

4679

29038

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4608

6917

13.65

307.65

5.0

2.0

324.47

376.83

nmol/l

35.12

4402

6424

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

983

927

11.88

307.65

3.2

1.4

478.34

346.21

mu/l

3.98

874

722

(3021387) Prolactin [Units/volume] in Serum or Plasma

2753

3065

12.91

307.65

3.8

1.3

423.06

283.51

mu/l

14.42

2662

2767

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2509

6457

5.12

307.65

5.9

2.1

11.18

13.19

nmol/l

26.90

2356

5890

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

730

192

41.53

307.65

1.8

1.2

1080.71

342.26

mu/l

4.50

706

183

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5409

34745

2.58

307.65

11.6

7.6

1.21

mmol/l

1.36

4668

30319

(3008295) Osmolality of Serum or Plasma

594

781

8.10

307.65

2.4

1.4

282.50

280.32

mosm/kgh2o

1.09

512

598

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

966

159

68.52

307.65

3.5

2.3

1.09

1.49

ug/l

1.60

915

151

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

403

343

12.28

307.65

2.6

1.4

6.44

4.38

nmol/l

0.50

346

262

(3009214) Lutropin [Units/volume] in Serum or Plasma

2277

2656

11.41

307.65

2.1

1.4

7.65

9.43

u/l

6.16

1783

2061

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

735

198

40.57

307.65

1.8

1.2

74.36

72.64

0.98

711

189

(43055514) Macroprolactin [Presence] in Serum or Plasma

602

142

45.57

307.65

1.7

1.2

—

(3018418) pH of Serum or Plasma

3630

20457

2.37

307.40

6.2

4.3

7.40

0.56

2795

14485

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

409

508

8.41

307.24

1.9

1.3

4.30

5.22

umol/l

3.36

355

448

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7274

56576

3.24

292.70

7.9

4.3

14.82

14.62

pmol/l

9.29

6995

52553

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

464

742

6.56

277.71

1.5

1.2

26.14

37.06

nmol/l

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

507

953

5.59

256.75

1.5

1.3

547.74

352.08

pmol/l

0.46

434

823

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

576

1241

4.91

249.62

1.9

1.3

17.56

25.17

u/l

6.84

484

1027

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1986

9601

2.40

226.52

7.9

7.1

1.06

1.07

mmol/l

0.90

1901

8999

(3013826) Glucose [Moles/volume] in Serum or Plasma

5709

41669

2.17

225.85

8.2

5.2

6.61

6.59

mmol/l

0.19

5495

39275

(3026782) Osmolality of Urine

2530

13583

2.24

225.17

3.9

2.9

502.55

538.71

mosm/kgh2o

12.93

2262

11953

(3024561) Albumin [Mass/volume] in Serum or Plasma

4595

30967

2.08

224.40

7.0

5.4

35.56

36.23

g/l

12.92

4371

29178

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4809

33066

2.07

220.94

3.7

2.6

76.36

75.54

nmol/l

1.31

4504

30531

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

474

974

5.09

216.74

2.3

1.2

1.04

2.39

nmol/l

0.34

462

942

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

480

1008

4.99

213.95

2.3

1.2

0.33

0.29

nmol/l

0.14

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

421

850

5.16

196.23

2.3

1.2

1.00

0.18

nmol/l

0.72

306

672

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2200

11820

2.17

190.25

5.0

4.2

0.81

0.82

mmol/l

0.96

2099

11190

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1243

5210

2.63

189.53

5.7

4.0

1.22

1.23

mmol/l

2.49

1156

4519

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2110

11318

2.15

182.08

3.1

2.7

2.38

2.36

g/l

0.46

1979

10529

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6678

53782

2.21

178.37

11.6

8.2

80.96

79.59

u/l

1.16

6468

51277

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1970

10407

2.17

175.96

3.2

2.7

22.71

22.93

0.28

1848

9738

(3022948) Iron [Moles/volume] in Serum or Plasma

2211

12212

2.10

175.82

3.2

2.7

13.02

13.48

umol/l

2.18

2092

11479

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5017

36704

1.92

173.66

8.4

6.7

10.71

11.58

umol/l

3.92

4819

34970

(3023368) Bacteria identified in Blood by Culture

2986

18459

1.96

172.51

6.1

4.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3294

21070

1.93

171.70

2.9

2.2

244.94

220.33

u/l

0.21

3158

20040

(3006315) Basophils [#/volume] in Blood

5166

38330

1.91

169.23

9.1

6.9

0.04

e9/l

0.04

4627

33031

(3001604) Monocytes [#/volume] in Blood

5158

38264

1.91

168.91

9.1

6.9

0.59

0.57

e9/l

7.62

4624

32978

(3013115) Eosinophils [#/volume] in Blood

5283

39542

1.91

167.80

9.5

7.2

0.19

e9/l

1.42

4768

34689

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3014

18860

1.93

166.61

2.9

2.4

2.87

2.72

mg/l

3.32

2692

16478

(3019198) Lymphocytes [#/volume] in Blood

5223

39180

1.89

161.95

9.2

6.9

1.96

1.95

e9/l

0.09

4754

34622

(3015377) Calcium [Moles/volume] in Serum or Plasma

3567

23742

1.88

161.79

4.1

3.5

2.34

2.36

mmol/l

8.05

3327

21768

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3392

22442

1.86

154.87

3.8

2.7

56.52

62.83

u/l

0.99

3178

20929

(42870588) Differential panel, method unspecified - Blood

3738

25493

1.84

154.75

8.8

7.0

—

3.66

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5515

42406

1.89

154.60

13.0

10.1

4.31

4.03

e9/l

9.78

4996

36726

(3019069) Monocytes/Leukocytes in Blood

4788

35306

1.83

152.70

9.5

7.2

8.62

8.72

1.57

4602

33306

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7620

66136

2.77

152.53

8.6

5.2

1.79

1.85

mu/l

0.71

7277

62125

(3032080) INR in Blood by Coagulation assay

4263

30369

1.82

152.07

15.1

13.1

1.18

1.22

inr

4.30

3697

25247

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1526

7690

2.20

150.97

9.1

8.6

5.08

5.10

kpa

0.35

1471

7406

(3027801) Oxygen [Partial pressure] in Arterial blood

1526

7690

2.20

150.97

9.1

8.6

12.71

12.78

kpa

0.17

1465

7406

(3006504) Eosinophils/Leukocytes in Blood

4771

35246

1.82

150.12

9.4

7.1

2.71

2.87

4.94

4577

33228

(3019977) pH of Arterial blood

1523

7689

2.20

149.88

9.2

8.7

7.42

0.66

926

4076

(3005719) IgG [Mass/volume] in Serum or Plasma

1304

6188

2.31

149.06

3.4

3.0

9.98

10.41

g/l

3.31

1157

5768

(3022096) Basophils/Leukocytes in Blood

4760

35210

1.82

148.39

9.5

7.2

0.66

0.68

3.36

4559

33165

(3003396) Base excess in Arterial blood by calculation

1510

7634

2.19

147.90

9.1

8.6

0.86

0.87

mmol/l

0.03

1248

6290

(3017181) Myelocytes/Leukocytes in Blood

1332

6414

2.28

146.91

5.6

4.7

0.96

0.92

0.20

498

1872

(3002030) Lymphocytes/Leukocytes in Blood

4856

36340

1.80

143.47

9.4

7.0

28.25

28.80

2.90

4698

34609

(3018010) Neutrophils/Leukocytes in Blood

4782

35701

1.79

141.61

9.0

6.9

57.04

56.41

3.12

4651

34252

(3016038) Potassium [Moles/volume] in Urine

267

482

5.68

140.53

1.6

1.4

33.70

36.47

mmol/l

0.88

243

435

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6459

52988

1.97

140.12

6.2

4.3

11.85

10.85

mm/h

6.96

6182

50043

(3021440) Promyelocytes/Leukocytes in Blood

1275

6143

2.27

139.91

5.7

4.8

0.07

0.11

1.64

441

1606

(3002179) Metamyelocytes/Leukocytes in Blood

1271

6134

2.26

138.83

5.3

4.5

0.59

0.67

0.86

465

1798

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1970

11310

1.97

135.44

2.5

1.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1184

5608

2.29

134.99

11.2

10.1

24.76

24.83

mmol/l

0.25

1177

5585

(3025159) Blasts/Leukocytes in Blood

1276

6249

2.23

134.16

6.0

4.9

0.04

0.30

2.06

407

1544

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2785

18153

1.80

127.16

3.7

3.3

1297.59

1223.08

ng/l

0.25

2364

15438

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4836

36855

1.74

126.99

4.2

3.2

119.91

111.08

ug/l

1.88

4591

34827

(3014576) Chloride [Moles/volume] in Serum or Plasma

1693

9431

2.00

125.80

9.4

8.0

103.88

104.44

mmol/l

4.20

1693

9424

(37021550) Renin [Units/volume] in Plasma --upright

132

119

11.24

125.31

2.0

1.2

93.18

55.75

mu/l

1.35

117

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

180

247

7.42

123.66

1.7

1.5

13.39

14.90

pmol/l

2.06

159

207

(3021589) Normoblasts [#/volume] in Blood

4453

33376

1.72

122.18

18.6

11.2

0.01

0.00

e9/l

0.56

3823

27061

(3010421) pH of Blood

599

2145

2.93

121.47

5.2

4.0

7.41

0.27

593

2125

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3558

25116

1.72

121.36

5.1

3.5

38.15

71.43

ng/l

0.91

2558

15844

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

231

421

5.61

120.29

1.5

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1098

5286

2.24

119.44

6.0

4.9

5.13

kpa

0.12

1066

5084

(3016502) Oxygen saturation in Arterial blood

1316

6834

2.10

117.93

9.6

9.1

95.60

95.82

0.56

1274

6597

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4053

29867

1.69

116.19

2.4

2.0

96.54

96.67

pmol/l

0.07

2264

16123

(1616796) Gas panel - Central venous blood

480

1554

3.21

115.88

5.3

4.0

—

(3009343) pH of Capillary blood

1070

5165

2.23

115.39

5.9

4.9

7.41

0.22

921

4239

(40767503) Oxygen content in Capillary blood by calculation

449

1406

3.31

114.47

3.5

2.6

16.50

16.72

0.74

439

1377

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1077

5290

2.19

110.97

4.8

4.5

84.89

85.67

ng/l

0.08

926

4664

(3000850) Epithelial cells [#/volume] in Urine

2449

15933

1.76

109.01

3.7

2.8

5.66

5.86

e6/l

0.34

2279

14497

(40760892) CBC W Ordered Manual Differential panel - Blood

2610

17326

1.74

107.96

7.0

4.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2786

18906

1.71

105.93

1.9

1.7

19.79

19.98

nmol/l

0.28

2470

16329

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

965

4631

2.22

105.02

5.9

4.9

1.82

1.57

mmol/l

1.48

743

3408

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

295

744

4.07

103.62

4.1

3.1

5.82

12.50

nmol/l

0.43

280

720

(4062490) Immunoglobulin typing, IgG

319

856

3.83

102.76

1.6

1.4

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

124

136

9.23

102.37

3.5

1.5

4.90

4.27

nmol/l

0.53

119

128

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1210

6401

2.04

101.97

10.3

9.4

123.81

122.10

g/l

2.04

1180

6256

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1475

8361

1.93

101.85

2.3

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

429

1405

3.16

101.41

1.7

1.6

0.69

0.76

g/l

0.61

256

1117

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1014

5030

2.15

101.36

2.1

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

3264

23297

1.66

101.23

4.6

3.4

62.92

76.53

e6/l

0.31

2675

17621

(3021901) Oxygen saturation in Capillary blood

430

1418

3.14

100.46

4.0

3.6

91.08

90.54

1.03

423

1384

(3020779) Urea [Moles/volume] in Serum or Plasma

1222

6552

2.01

98.97

10.4

8.8

8.72

8.93

mmol/l

0.52

1177

6315

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2785

19195

1.68

98.14

1.5

1.4

1.25

1.90

u/ml

3.33

841

5235

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3465

25245

1.64

98.14

4.2

3.4

36.36

33.50

u/l

0.48

3282

23951

(3012501) Base excess in Blood by calculation

425

1411

3.12

98.13

5.6

4.3

2.57

2.41

mmol/l

0.53

311

941

(3013290) Carbon dioxide [Partial pressure] in Blood

425

1412

3.11

98.01

5.6

4.3

5.04

5.01

kpa

0.27

418

1390

(3027945) Reticulocytes/Erythrocytes in Blood

1392

7839

1.93

97.64

3.2

3.0

1.83

1.74

2.50

1235

7066

(3027315) Oxygen [Partial pressure] in Blood

425

1420

3.10

97.05

5.6

4.3

8.60

8.79

kpa

1.36

418

1397

(3027135) IgG subclass 1 [Mass/volume] in Serum

315

873

3.71

96.80

1.6

1.4

6.09

6.69

g/l

1.84

167

648

(3024139) IgG subclass 3 [Mass/volume] in Serum

315

873

3.71

96.80

1.6

1.4

0.36

0.39

g/l

0.66

164

648

(3028192) IgG subclass 2 [Mass/volume] in Serum

315

874

3.70

96.64

1.6

1.4

2.59

2.85

g/l

1.54

165

652

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1398

7938

1.91

95.45

2.4

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

971

4846

2.13

95.22

2.0

1.19

1.31

g/l

1.26

919

4523

(3007164) IgA [Mass/volume] in Serum or Plasma

2515

17024

1.68

94.09

1.8

1.5

2.35

2.29

g/l

0.59

1663

10681

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2132

13819

1.73

93.59

1.9

1.7

33369782.14

28072840.98

pmol/l

0.16

1852

11766

(3030467) Casts [#/volume] in Urine by Automated count

2878

20227

1.64

92.71

4.5

3.3

0.35

0.38

e6/l

0.26

2297

14670

(3010838) Calcium [Moles/time] in 24 hour Urine

380

1231

3.18

91.39

2.2

1.9

4.67

5.08

mmol/24h

1.59

344

1109

(3031040) Bacteria [#/volume] in Urine by Automated count

5617

46477

1.64

91.19

6.4

4.4

1636.92

1476.37

e6/l

0.08

594

(3019309) Folate [Moles/volume] in Red Blood Cells

1704

10448

1.79

90.41

2.0

1.7

1273.29

1157.58

nmol/l

5.21

1338

8065

(3001556) Androgen free Index in Serum or Plasma

11.59

90.26

1.9

1.1

—

(3026008) Bacteria identified in Urine by Culture

2873

20293

1.63

90.08

4.1

3.0

—

(3023520) Reticulocytes [#/volume] in Blood

1107

5919

2.00

89.73

2.8

2.9

73.70

69.50

e9/l

2.97

812

4218

(3029937) Albumin [Presence] in Urine by Test strip

2902

20573

1.63

89.52

5.4

3.9

0.00

estimate

0.24

1327

7292

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

699

3139

2.34

88.49

2.1

2.0

38.73

39.95

u/l

0.83

644

2844

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1340

7685

1.88

88.08

7.6

4.9

5.88

5.82

kpa

1.48

1302

7497

(3015235) Bicarbonate [Moles/volume] in Capillary blood

584

2425

2.51

87.93

3.9

3.8

24.70

24.64

mmol/l

0.15

576

2386

(3028271) Lactate [Moles/volume] in Capillary blood

338

1057

3.29

86.13

2.6

1.9

1.73

1.67

mmol/l

0.53

329

1032

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7277

64990

1.94

86.05

7.8

5.8

39.47

38.62

mmol/mol

12.09

6966

61568

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1241

7004

1.90

85.50

2.7

2.6

0.22

0.21

g/l

0.89

1164

6586

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1065

5720

1.99

84.93

1.3

1.2

117.10

144.21

u/ml

1.40

385

2132

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

11.38

84.43

3.5

1.9

20.60

1.93

nmol/l

2.20

(3012544) pH of Venous blood

1338

7790

1.85

83.48

7.7

4.9

7.38

7.37

0.16

852

4562

(3021601) Nitrite [Presence] in Urine by Test strip

4769

38355

1.57

83.46

5.2

3.7

0.00

estimate

0.35

1389

7826

(3035350) Ketones [Presence] in Urine by Test strip

4808

38744

1.57

83.39

5.2

3.7

4.24

4.34

estimate

0.02

1409

7958

(3019550) Sodium [Moles/volume] in Serum or Plasma

7767

71195

2.33

83.11

31.5

16.8

139.40

139.67

mmol/l

14.72

7692

69844

(3002032) Base excess in Venous blood by calculation

1299

7523

1.86

82.32

7.7

5.0

1.94

1.69

mmol/l

1.88

1154

6557

(3009261) Glucose [Presence] in Urine by Test strip

4826

38983

1.56

82.30

5.2

3.8

0.01

0.19

estimate

0.69

1343

7561

(4035726) Immunohistochemistry procedure

1080

5893

1.95

82.09

1.5

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5813

49030

1.61

82.07

6.2

4.4

3.00

2.67

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1178

6619

1.91

82.00

4.7

3.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

278

799

3.56

80.86

2.4

1.8

89.11

90.33

2.15

270

787

(3037522) Nuclear Ab [Titer] in Serum

1741

11053

1.73

80.61

1.6

1.4

506.41

525.49

titre

0.16

362

2272

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1334

7857

1.83

79.86

4.4

4.7

244.39

241.81

u/l

0.17

1269

7491

(3018095) Leukocytes [#/volume] in Urine

3570

27079

1.55

79.84

5.5

4.0

66.50

84.36

e6/l

1.06

2772

18787

(3023103) Potassium [Moles/volume] in Serum or Plasma

7768

71390

2.29

79.46

31.6

17.0

3.94

3.96

mmol/l

6.04

7685

69884

(36304419) Bacteria [Presence] in Urine

2724

19470

1.59

78.76

4.4

3.2

6.10

207.35

estimate

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1007

5438

1.97

78.69

2.9

2.7

65.57

66.66

g/l

4.57

945

5041

(3000991) Gas panel - Venous blood

1181

6726

1.88

78.61

11.6

10.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

814

4077

2.10

78.35

10.2

11.1

24.15

24.26

mmol/l

0.50

799

4005

(40761536) Microorganisms panel - Urine sediment

1045

5769

1.93

76.37

5.7

3.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2355

16363

1.61

76.15

2.2

2.0

1.07

1.18

mg/l

0.76

1835

12543

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

131

216

6.14

75.69

2.4

1.8

0.14

0.20

nmol/l

0.99

106

164

(3014111) Lactate [Moles/volume] in Serum or Plasma

1131

6430

1.88

75.47

10.6

9.0

1.31

1.32

mmol/l

0.08

1110

6307

(3009508) Creatinine [Moles/volume] in Urine

3206

23952

1.55

75.47

4.3

3.6

7.66

7.89

mmol/l

1.79

2800

20688

(3013512) EKG study

2992

22023

1.56

75.25

4.2

3.4

0.50

0.76

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1688

10812

1.70

74.96

2.6

29.46

29.67

0.84

1644

10550

(3007853) Bacteria identified in Skin by Aerobe culture

1423

8719

1.76

74.03

2.3

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

1141

6550

1.86

73.73

7.2

4.5

4.61

4.69

kpa

0.81

1106

6383

(3008152) Bicarbonate [Moles/volume] in Arterial blood

783

3953

2.08

73.61

9.0

6.8

24.59

24.45

mmol/l

0.43

751

3779

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

582

2655

2.28

70.58

8.4

7.2

1.48

1.37

mg/l

2.45

539

2500

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

490

2077

2.44

70.26

1.4

1.6

523.04

511.36

mg/l

0.20

467

1989

(3028626) Oxygen [Partial pressure] in Capillary blood

578

2638

2.28

70.00

7.0

5.6

8.82

8.94

kpa

0.71

571

2569

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

451

1849

2.52

69.47

1.3

1.6

3.65

3.70

mmol/l

0.41

419

1752

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

460

1912

2.49

68.81

1.9

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

464

1949

2.46

67.83

2.1

9.67

11.41

mg/l

4.32

432

1829

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3717

29115

1.50

67.60

5.2

3.6

0.01

0.21

estimate

1.11

1188

6488

(3042936) Bacteria identified in Isolate by Culture

1570

10107

1.68

67.57

2.6

2.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2862

21279

1.52

66.62

4.7

3.1

0.02

0.14

estimate

1.24

1168

6302

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

447

1861

2.48

66.60

1.5

1.8

771.27

3365.12

e6/l

0.67

361

1450

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

442

1831

2.49

66.56

1.5

1.7

61.64

24.02

e6/l

0.61

329

1336

(3017732) Neutrophils [#/volume] in Blood

1475

9395

1.69

65.91

3.5

3.2

4.64

4.49

e9/l

0.27

1303

8269

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

551

2532

2.26

65.56

2.5

1.9

2.76

2.10

ug/l

0.27

502

2265

(3014007) Fractional oxyhemoglobin in Arterial blood

833

4500

1.94

64.36

10.9

11.0

94.05

94.10

0.07

828

4487

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

829

4486

1.94

63.70

10.8

10.9

1.32

1.33

0.13

821

4458

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

184

469

3.99

63.67

2.7

3.1

100.12

163.39

nmol/l

0.70

184

464

(3015171) Extractable nuclear Ab [Units/volume] in Serum

619

3015

2.14

63.65

1.4

1.3

0.66

1.02

u/ml

0.39

244

(3020891) Body temperature

625

3058

2.13

63.52

5.7

4.6

36.92

°c

0.00

612

3034

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

461

1989

2.39

63.47

2.0

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

209

586

3.63

63.09

1.7

1.3

139.63

186.38

pmol/l

1.86

209

586

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

806

4340

1.95

62.80

11.0

11.2

0.66

0.65

0.25

800

4311

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1897

13021

1.59

62.42

3.4

2.9

2.44

mmol/l

0.06

1720

11651

(3009445) Proteinase 3 Ab [Units/volume] in Serum

618

3052

2.10

61.24

1.5

1.6

5.09

14.97

iu/ml

2.42

(3005322) IgE [Units/volume] in Serum or Plasma

964

5573

1.82

60.10

1.8

1.3

371.02

226.39

u/ml

0.80

907

5214

(3004119) Hemoglobin [Mass/volume] in Venous blood

789

4283

1.93

59.90

7.0

4.0

130.06

130.27

g/l

0.09

762

4164

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

240

761

3.21

59.72

1.6

1.5

—

(40768797) Stomach Pathology biopsy report

1497

9811

1.64

59.21

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

226

695

3.31

59.12

2.3

3.4

19.50

25.86

mu/l

2.41

212

660

(3044889) 12 lead EKG panel

5585

48230

1.48

57.27

4.8

3.7

0.23

4847.88

0.68

(3012516) Albumin [Mass/volume] in Urine

2777

21010

1.48

57.16

3.8

3.5

50.20

51.60

mg/l

0.12

1860

13603

(3027273) Bicarbonate [Moles/volume] in Venous blood

588

2924

2.09

57.11

5.2

3.7

25.18

25.29

mmol/l

0.32

563

2816

(3020682) Albumin/Creatinine [Ratio] in Urine

2810

21324

1.48

56.90

4.6

4.2

9.15

9.76

mg/mmol

0.21

1826

13551

(3002079) Sodium [Moles/time] in 24 hour Urine

143

337

4.30

54.99

1.2

1.3

171.39

161.51

mmol/24h

0.45

143

337

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

537

2622

2.12

54.68

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

388

1660

2.40

54.34

2.9

2.3

129.24

131.32

g/l

0.96

336

1304

(3015736) pH of Urine

3841

31124

1.43

54.03

4.3

3.3

6.26

6.21

1.52

2203

17565

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

448

2053

2.25

53.49

1.5

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

573

2894

2.05

53.28

7.7

5.1

1.54

1.63

1.94

544

2736

(3025941) Bacteria identified in Stool by Culture

758

4214

1.88

53.26

1.4

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7231

66355

1.67

53.25

6.0

4.7

5.88

5.85

mmol/l

1.57

6866

61871

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

624

3254

1.99

53.06

6.0

4.2

47.80

48.54

0.31

607

3201

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

441

2016

2.25

52.96

2.1

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

274

1003

2.79

52.88

1.8

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

324

1295

2.56

52.53

1.9

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

2490

18676

1.47

52.52

5.4

4.5

92.53

91.01

2.36

2429

18300

(3048689) Calprotectin [Mass/mass] in Stool

1600

10940

1.57

52.27

2.7

135.52

125.07

ug/g

0.52

1305

8828

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

162

5.79

50.86

1.7

1.6

0.40

0.38

ug/l

0.09

119

(3035933) Granulocytes/Leukocytes in Blood

400

1785

2.30

50.85

4.1

3.2

58.43

57.32

0.90

400

1785

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7251

66759

1.66

50.57

23.9

14.0

84.55

85.58

ml/min/173m2

3.60

6857

61043

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

180

530

3.45

50.47

1.8

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

442

2064

2.20

50.36

4.4

3.8

1.37

1.39

mmol/l

0.19

433

2026

(3026493) Urate [Moles/volume] in Serum or Plasma

2446

18405

1.46

50.27

3.1

2.7

339.00

336.36

umol/l

0.59

2167

16538

(3023183) Ammonium ion [Moles/volume] in Plasma

377

1653

2.34

49.92

2.9

3.0

31.92

34.86

umol/l

1.66

340

1517

(3044640) Blood type and Crossmatch panel - Blood

2979

23300

1.43

49.60

3.1

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

293

1148

2.61

49.48

1.5

20.00

10.24

u/ml

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7646

71527

1.83

49.01

25.9

14.9

21.21

23.18

mg/l

7.34

6710

58173

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

261

970

2.74

48.93

1.8

1.6

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

281

1086

2.64

48.78

1.9

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2523

19212

1.45

48.27

5.7

4.9

2.25

2.67

ug/l

0.36

2311

17556

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

382

1710

2.29

48.19

6.8

1028.77

1591.94

iu/ml

0.22

242

(3007930) Methemoglobin/Hemoglobin.total in Blood

522

2654

2.03

47.56

7.9

5.4

0.86

0.88

0.68

494

2507

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

696

3899

1.85

47.55

12.3

11.4

16.20

16.08

0.52

674

3768

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

648

3557

1.89

47.17

1.7

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

442

2130

2.13

46.46

1.8

2.1

20.39

6.37

iu/l

0.39

184

913

(3022313) Gas panel - Capillary blood

677

3794

1.85

46.15

6.4

5.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

229

821

2.84

45.97

1.8

2.3

31.93

32.51

1.04

229

814

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

380

1734

2.25

45.78

1.8

1.4

—

(3000012) Reticulocyte production index

239

879

2.77

45.72

1.9

2.2

0.96

0.88

1.37

175

576

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

491

2482

2.04

45.42

2.3

2.4

426.21

582.64

ug/l

0.60

461

2346

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4037

33621

1.39

45.30

3.5

2.8

—

estimate

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

73.36

44.96

3.6

1.1

2.65

6.40

mu/l

—

(3011412) CD3 cells [#/volume] in Blood

232

852

2.77

44.51

2.5

2.7

1274.63

1236.96

e6/l

0.25

191

719

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

8.33

44.43

3.8

2.6

100.30

80.33

pmol/l

0.17

(3042631) Mycobacterium sp identified in Specimen

224

809

2.81

44.36

3.2

2.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

444

2182

2.09

44.31

1.5

1.4

263.35

283.19

ug/g

1.23

258

1241

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

190

628

3.07

44.13

1.6

1.3

1.33

3.77

u/ml

2.95

117

372

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

249

4.42

43.68

1.8

2.7

121.79

121.94

ng/l

0.00

167

(3023419) Bacteria identified in Sputum by Culture

228

839

2.76

43.58

4.1

2.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

295

1232

2.44

43.55

1.3

245.00

421.65

titre

0.88

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

327

1430

2.34

43.54

1.8

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

295

1237

2.43

43.17

1.3

46.67

210.00

titre

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

188

626

3.05

43.11

1.3

2.09

2.05

mmol/l

0.17

170

583

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

322

1410

2.33

42.74

1.7

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

313

1358

2.35

42.44

4.6

4.4

19486.11

1017.80

u/ml

0.47

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

827

5033

1.71

42.41

8.5

5.3

24.35

24.08

mmol/l

1.94

818

4995

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5760

51181

1.40

42.01

4.8

3.4

53.12

44.67

u/l

7.92

5499

48681

(3034860) Kappa light chains.free [Mass/volume] in Serum

413

2030

2.09

41.18

3.7

3.5

50.72

77.85

mg/l

0.46

324

1717

(1175426) CD3 cells/Lymphocytes in Blood

203

726

2.84

40.96

2.5

75.50

71.63

3.32

193

703

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

473

2448

1.99

40.90

1.8

0.24

0.23

g/l

0.59

450

2340

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

197

700

2.86

40.23

2.4

2.5

12.52

13.46

0.74

191

688

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

480

2524

1.95

39.63

1.8

1.23

1.18

g/l

2.47

461

2419

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

408

2029

2.06

39.41

3.8

3.5

31.92

54.64

mg/l

2.06

319

1717

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

140

5.39

38.15

1.2

307.69

278.10

pmol/l

0.24

106

(3022145) Colonoscopy Study observation

1202

8219

1.54

38.03

1.4

—

(3000494) Fungus identified in Specimen by Culture

1293

8993

1.52

37.77

1.8

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

273

1175

2.37

37.70

1.2

30.49

36.03

u/l

0.18

237

1030

(3037756) Immunofixation for Serum or Plasma

280

1219

2.34

37.67

1.6

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

419

2141

2.01

37.54

3.0

2.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1257

8703

1.52

37.48

3.6

3.2

6.69

7.82

umol/l

1.48

1053

7593

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

288

1283

2.29

36.73

1.4

3.49

4.22

ug/l

0.54

259

1150

(3004809) Band form neutrophils/Leukocytes in Blood

260

1112

2.38

36.43

3.7

3.5

1.26

1.55

0.70

230

998

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

566

3228

1.81

36.23

7.1

5.2

24.81

24.57

mmol/l

1.20

536

3055

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

364

1814

2.05

34.94

3.7

3.3

5.49

3.23

ratio

0.46

194

1026

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3551

29788

1.33

34.28

2.1

1.9

1.54

1.38

mmol/l

17.34

3028

25653

(3020564) Creatinine [Moles/volume] in Serum or Plasma

7887

75409

1.84

34.14

32.5

18.4

78.78

74.85

umol/l

14.67

7821

74605

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6662

61455

1.41

33.50

31.0

18.2

13.73

13.49

39.00

6611

60695

(3007566) Smooth muscle Ab [Titer] in Serum

425

2270

1.92

33.44

1.3

1.4

124.04

123.69

titre

0.00

217

(40758558) Short blood count panel - Blood

2759

22375

1.35

33.19

8.3

6.8

—

(3004451) EKG impression Narrative

118

350

3.40

32.83

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

130

413

3.18

32.38

1.8

1.5

—

(3012565) Volume of 24 hour Urine

118

355

3.35

32.11

2.0

2.2

2278.64

2028.08

0.94

110

328

(3026389) Candida sp identified in Specimen by Organism specific culture

247

1092

2.30

32.10

1.6

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

149

515

2.92

32.08

11.4

13.6

0.60

0.61

mmol/l

0.04

134

472

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

209

859

2.47

32.00

1.2

1.1

85.40

54.37

au/ml

—

(3034770) Mitochondria Ab [Titer] in Serum

414

2243

1.89

31.18

1.3

1072.73

938.83

titre

0.15

(3009466) Valproate [Moles/volume] in Serum or Plasma

248

1113

2.26

31.11

7.1

5.5

371.12

371.18

umol/l

0.00

225

992

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

439

3.06

31.06

1.8

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1835

14078

1.39

31.00

1.5

1.3

26.06

28.01

iu/ml

0.26

523

4205

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

124

394

3.18

30.89

1.9

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

165

616

2.71

30.77

1.2

115.56

110.32

pmol/l

0.61

165

616

(3033923) Metanephrine [Moles/time] in 24 hour Urine

119

5.24

30.64

1.4

1.1

28.34

0.71

umol/24h

0.49

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

514

3002

1.76

30.26

1.9

1.8

1.54

1.49

g/l

0.60

441

2609

(3047181) Lactate [Moles/volume] in Blood

371

1961

1.93

30.11

8.9

5.9

1.32

1.28

mmol/l

0.42

323

1731

(46235355) HIV 1 and 2 tests - Meaningful Use set

2149

16975

1.36

30.10

2.1

2.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

545

3251

1.72

29.76

1.9

8.06

6.68

iu/ml

0.52

123

771

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

827

5482

1.56

29.64

2.6

2.4

19.10

20.06

au/ml

0.10

638

(3017143) Hepatitis C virus Ab [Presence] in Serum

1372

10092

1.43

29.38

1.8

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

839

5594

1.55

29.28

3.0

2.5

0.36

0.40

e6/l

0.21

803

5333

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

773

5071

1.58

28.96

1.4

1.3

52.80

51.35

au/ml

0.06

314

(3040151) Glucose [Moles/volume] in Capillary blood

192

798

2.44

28.73

6.0

13.0

7.27

7.18

mmol/l

0.11

166

681

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

117

379

3.11

28.25

1.3

53.22

69.04

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2231

17881

1.34

27.97

3.1

2.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

188

785

2.42

27.86

2.4

2.7

41.50

38.92

1.53

182

774

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

100

297

3.39

27.82

4.8

4.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

199

859

2.35

27.38

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

172

697

2.50

27.20

4.2

4.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

385

2129

1.85

27.19

1.4

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1685

13003

1.37

26.92

1.4

1.3

6.83

10.09

u/ml

1.98

690

5236

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

163

649

2.54

26.75

2.4

2.9

528.96

506.21

e6/l

0.22

116

508

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

392

3.01

26.69

1.8

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

638

4082

1.61

26.51

2.1

1.7

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

353

1916

1.88

26.44

1.4

1.3

22.94

17.27

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6973

65469

1.39

26.30

5.0

4.1

1.44

1.29

mmol/l

41.28

6565

61352

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

412

2350

1.79

26.28

1.4

1.3

42.95

33.45

u/ml

0.21

127

(36660697) Celiac disease serology panel - Serum

980

6900

1.47

26.25

1.3

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

106

5.12

26.06

1.9

2.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

276

1391

2.02

25.72

1.7

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

576

3622

1.63

25.67

1.7

1.8

0.27

0.31

mg/l

1.03

238

1742

(3010370) Gastrin [Moles/volume] in Serum or Plasma

109

4.97

25.25

3.1

1.8

43.78

44.58

pmol/l

0.02

(3045414) Leukocytes [Presence] in Urine

947

6682

1.47

25.02

2.2

2.1

0.02

estimate

0.12

257

1462

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

161

663

2.45

24.63

2.5

3.0

209.06

209.37

e6/l

0.01

121

539

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

265

1337

2.01

24.63

1.2

1.1

31.41

8799.80

iu/ml

0.64

307

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

129

477

2.73

24.59

1.6

1.5

6.35

5.89

u/l

0.15

116

415

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

602

3868

1.60

24.54

2.5

2.4

5530.36

6085.02

u/l

0.15

177

1489

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7796

74983

1.60

24.02

17.3

11.6

29.54

26.87

u/l

3.98

7678

73161

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

156

641

2.46

23.99

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

382

2191

1.78

23.91

1.4

1.3

6.85

9.21

u/ml

0.37

320

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

382

2194

1.77

23.80

1.4

1.3

2.13

5.85

u/ml

1.44

197

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

327

1794

1.85

23.69

1.3

33.95

39.25

u/ml

0.29

161

(3039000) Anion gap in Blood by calculation

260

1324

1.99

23.56

10.9

7.1

11.29

11.30

mmol/l

0.01

236

1188

(3018572) Chloride [Moles/volume] in Blood

260

1325

1.99

23.51

10.9

7.1

104.70

105.15

mmol/l

0.60

236

1189

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

329

1813

1.85

23.51

1.4

1.3

2.29

3.95

u/ml

0.52

110

(3017569) Oxygen content in Arterial blood

100

330

3.05

23.47

2.4

15.90

16.40

0.63

100

330

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

129

4.44

23.26

1.6

1.2

—

(3023410) Appearance of Cerebral spinal fluid

196

902

2.20

23.22

1.7

2.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

448

2.72

23.03

1.2

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1514

11738

1.35

23.03

4.1

3.1

3.54

2.69

e6/l

2.02

818

5614

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

2559

1.70

22.88

2.9

2.3

3.55

3.71

g/l

1.63

400

2372

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

2561

1.70

22.81

2.9

2.3

4.19

4.24

g/l

0.65

399

2374

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1673

13184

1.33

22.78

4.9

3.8

409.11

497.03

ng/l

0.28

1198

9581

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

427

2564

1.70

22.72

2.9

2.3

7.29

7.33

g/l

0.17

398

2373

(3020961) Endomysium IgA Ab [Titer] in Serum

640

4251

1.55

22.54

1.2

89.62

202.18

titre

1.58

147

(3006653) Thiamine [Moles/volume] in Blood

107

376

2.87

22.48

1.2

1.3

138.71

137.48

nmol/l

0.11

107

376

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

715

4882

1.51

22.13

3.6

3.1

135.78

175.13

ng/l

2.76

646

4422

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

181

826

2.22

21.91

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

162

706

2.32

21.88

1.2

1.1

41.29

38.83

mg/l

0.23

127

593

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

642

4298

1.53

21.80

1.2

1.06

18.22

u/ml

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

118

444

2.68

21.79

2.5

2.8

29.77

27.07

1.25

112

433

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

135

543

2.51

21.77

1.2

1.1

—

(3019225) pH of Specimen

856

6078

1.45

21.75

5.2

4.1

7.36

7.35

1.07

676

4369

(3003327) Ova and parasites identified in Stool by Light microscopy

491

3103

1.62

21.41

1.8

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

403

2424

1.69

21.31

2.9

2.3

2.80

2.88

g/l

1.01

376

2235

(3045424) Erythrocytes [Presence] in Urine

531

3426

1.59

21.23

2.3

2.1

0.01

0.22

estimate

0.47

210

1149

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

279

1509

1.88

21.17

1.4

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

330

1880

1.78

21.16

6.0

2.9

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

203

984

2.09

21.09

7.8

7.0

12.17

11.39

mg/l

1.48

184

930

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

441

2727

1.65

20.98

2.9

3.7

96.89

93.80

2.02

429

2640

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

359

2109

1.73

20.69

3.7

4.7

0.34

iu/ml

0.11

214

1146

(3024928) Oxygen saturation in Venous blood

330

1897

1.77

20.52

8.9

4.4

63.61

63.14

0.15

313

1854

(3013005) Retinol [Moles/volume] in Serum or Plasma

124

493

2.54

20.51

2.4

2.5

2.14

1.84

umol/l

2.99

119

464

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1602

12732

1.32

20.26

3.9

3.0

1.24

1.04

e6/l

0.38

915

6635

(21494814) CD8 cells/Lymphocytes in Specimen

289

3.03

20.24

2.3

2.1

29.72

29.95

0.05

289

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

415

2556

1.65

20.05

3.6

3.7

3.45

g/l

0.01

394

2448

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1884

15323

1.29

20.05

4.5

4.0

22.21

21.78

0.50

832

6765

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1325

10261

1.34

20.02

1.9

1.8

1.50

1.43

2.56

1145

9158

(3006245) CD3-CD19+ cells/cells in Blood

120

476

2.54

19.96

2.7

3.1

10.94

12.32

0.58

110

460

(3008037) Lactate [Moles/volume] in Venous blood

274

1505

1.85

19.82

4.9

3.0

1.45

1.53

mmol/l

0.90

264

1461

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

154

686

2.27

19.80

1.1

278.22

251.32

mg/l

0.45

128

605

(3037121) Protein [Mass/volume] in Urine

408

2514

1.65

19.68

4.0

304.21

431.24

mg/l

1.49

218

1260

(44790048) Parainfluenza type 2 nucleic acid detection

208

1046

2.01

19.58

2.0

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

208

1046

2.01

19.58

2.0

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

266

1457

1.85

19.42

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

156

705

2.23

19.39

1.3

1.2

65.60

75.61

u/l

0.58

141

621

(3042111) Morphology [Interpretation] in Bone marrow Narrative

211

1071

1.99

19.36

1.6

1.7

—

(44790049) Parainfluenza type 3 nucleic acid detection

207

1046

2.00

19.23

2.0

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

207

1046

2.00

19.23

2.0

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

331

2.83

19.15

1.1

549.93

239.75

ng/l

0.55

(3036489) Thrombin time

474

3053

1.58

19.08

2.8

2.9

20.71

21.12

1.01

413

2704

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

129

543

2.39

18.91

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

118

479

2.48

18.73

1.2

1.1

1.26

1.08

u/l

0.96

198

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7251

69246

1.36

18.58

5.9

4.8

4.57

4.67

mmol/l

16.41

6906

65704

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

414

2602

1.62

18.46

2.4

2.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

366

2.69

18.43

1.2

1.1

93.07

85.13

u/l

0.24

331

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1733

14075

1.29

18.41

1.9

1.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

384

2378

1.64

18.17

2.2

1.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7214

68887

1.34

18.10

5.8

4.7

1.39

1.45

mmol/l

27.58

6838

65013

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

364

2.68

18.08

1.2

1.1

37.35

23.37

u/l

0.53

329

(3042517) Benzodiazepines panel - Urine

112

4.21

18.02

4.6

2.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7311

69964

1.36

18.00

6.5

5.3

2.68

2.77

mmol/l

13.84

6949

66116

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

364

2230

1.66

17.97

3.1

2.3

0.44

0.86

g/l

2.63

316

1939

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

158

743

2.15

17.83

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

394

2469

1.62

17.79

3.5

3.3

181.01

184.23

0.32

382

2365

(21494755) Public health laboratory ask at order entry panel

588

8361

0.68

17.62

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

404

2.57

17.59

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

155

728

2.15

17.55

1.3

1.4

1.70

1.47

nmol/l

1.52

140

657

(3016650) Hepatitis A virus Ab [Presence] in Serum

250

1388

1.82

17.51

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

908

6766

1.38

17.39

1.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

112

460

2.45

17.37

1.1

1.21

11.54

nmol/l

1.81

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

128

561

2.30

17.16

2.6

3.5

101.25

96.37

0.75

122

534

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

772

5612

1.41

17.10

3.3

2.7

67.53

70.22

ml/min/173m2

1.05

366

2331

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

207

3.20

16.98

2.0

2.4

17.18

16.11

umol/l

0.31

207

(3044242) Glucose [Moles/volume] in Arterial blood

339

2.67

16.69

2.2

2.3

7.46

8.04

mmol/l

0.80

339

(3039162) Centromere protein B Ab [Units/volume] in Serum

192

995

1.95

16.65

1.4

1.3

48.09

62.14

u/ml

0.32

(4027681) Cerebrospinal fluid IgG ratio and IgG index

124

544

2.30

16.60

1.4

1.2

0.62

0.63

ratio

0.04

316

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

2198

1.64

16.60

3.1

2.3

9.31

10.29

g/l

4.01

323

1992

(3020876) Protein [Mass/time] in 24 hour Urine

161

786

2.07

16.51

2.5

2.4

0.97

1.40

g/24h

1.69

474

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

268

1548

1.75

16.45

2.5

2.3

0.99

0.83

nmol/l

2.77

232

1327

(40768443) Skin Pathology biopsy report

472

3144

1.53

16.37

1.3

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

947

7187

1.36

16.11

3.1

2.6

60.87

44.20

u/l

0.28

809

6111

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

735

5361

1.41

15.94

1.7

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

313

1911

1.66

15.69

3.0

2.2

0.01

0.03

g/l

1.40

284

1731

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.52

15.58

1.2

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

162

812

2.01

15.48

1.8

1.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

192

1023

1.90

15.36

1.2

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

122

552

2.23

15.22

17.9

21.1

1405.06

3106.19

nmol/l

0.49

117

535

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

966

7426

1.34

15.05

9.5

6.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

144

700

2.07

14.98

3.7

3.5

57.08

57.32

0.05

122

603

(3011288) Drugs identified in Urine by Screen method Nominal

451

3037

1.51

14.87

7.9

3.1

—

(3052851) Hemolysis interference index of Serum or Plasma

318

1981

1.63

14.75

3.3

3.2

1.96

2.67

index

0.95

177

1048

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

146

721

2.04

14.57

1.9

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1421

11558

1.28

14.52

3.4

3.0

0.73

ug/l

0.05

890

6927

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

5.39

14.43

3.4

2.9

312.74

95.39

pmol/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

404

2675

1.53

14.42

1.6

1.5

0.13

3.30

iu/ml

0.69

490

(3000060) B lymphocytes [#/volume] in Blood

395

2.42

14.42

2.6

3.0

0.27

0.25

e9/l

0.12

221

(3019420) Tryptase [Mass/volume] in Serum or Plasma

110

494

2.24

14.01

1.8

1.5

9.65

7.58

ug/l

0.27

442

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

301

1875

1.63

13.98

1.7

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

395

2.39

13.95

1.7

1.6

1.72

1.27

nmol/l

2.06

292

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

246

1455

1.71

13.94

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

246

1455

1.71

13.94

1.4

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

705

5223

1.38

13.90

3.2

2.3

5.71

7.63

ug/l

2.10

598

4629

(3006922) Hepatitis E virus Ab [Presence] in Serum

137

675

2.04

13.78

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

296

1843

1.63

13.78

3.1

2.2

0.00

g/l

-0.00

260

1623

(3019150) Specific gravity of Urine by Refractometry

2013

17121

1.23

13.77

5.0

3.8

1.02

1.29

kg/l

1.08

1378

11240

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

203

2.97

13.65

1.2

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

249

2.74

13.40

1.3

1.2

24.00

18.47

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

164

3.18

13.34

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

140

3.37

13.21

2.5

3.2

26.91

35.48

mg/l

0.25

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

280

1738

1.63

13.21

1.7

1.6

139.44

138.77

au/ml

0.03

524

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5471

51169

1.20

13.16

3.6

3.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

475

3315

1.46

13.12

2.3

2.4

—

(3038515) Glucose [Moles/volume] in Venous blood

214

1239

1.74

13.11

5.2

3.1

7.33

7.43

mmol/l

0.16

207

1202

(3018851) Theophylline [Moles/volume] in Serum or Plasma

5.33

12.73

2.4

1.7

47.76

47.13

umol/l

0.03

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

232

1387

1.69

12.67

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

395

2.32

12.60

1.2

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

145

756

1.93

12.47

1.9

1.6

59.01

55.91

0.42

101

463

(3003329) Lymphocytes/Leukocytes in Synovial fluid

120

585

2.06

12.46

2.0

1.5

30.16

32.24

0.24

346

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

234

1414

1.67

12.29

2.7

2.4

130.88

111.71

ug/min

0.19

144

886

(3002256) Pathology report gross observation

1152

9316

1.27

12.17

1.4

1.3

—

(3007461) Platelets [#/volume] in Blood

8006

78391

1.52

12.13

39.0

22.5

259.85

255.39

e9/l

7.27

7918

76920

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

435

2.22

12.03

1.9

1.5

36491.00

1368513.23

iu/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

391

2.29

12.01

2.8

2.3

203.91

164.44

umol/l

0.29

203

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

271

1711

1.60

11.96

3.1

2.2

0.00

g/l

-0.00

260

1621

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8006

78409

1.51

11.91

38.9

22.4

90.40

90.49

0.96

7966

77733

(3035941) MCH [Entitic mass]

8006

78410

1.51

11.90

38.8

22.4

30.08

30.19

6.73

7965

77736

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

115

562

2.06

11.89

1.5

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.52

11.84

1.5

1.1

14.87

1.65

umol/24h

0.50

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8006

78418

1.51

11.80

39.9

23.0

41.01

41.17

0.11

7966

77701

(3026361) Erythrocytes [#/volume] in Blood

8006

78420

1.51

11.78

39.0

22.4

4.53

e12/l

0.17

7900

76756

(3014271) Vancomycin [Susceptibility]

255

2.60

11.76

2.9

2.8

—

(3010813) Leukocytes [#/volume] in Blood

8007

78433

1.51

11.76

39.1

22.5

7.07

6.70

e9/l

16.48

7897

76744

(1001926) Buprenorphine [Presence] in Urine by Screen method

485

3469

1.42

11.75

4.9

2.2

—

(3014051) Protein [Presence] in Urine by Test strip

2471

21708

1.19

11.74

3.7

2.8

0.02

0.05

0.60

399

(3003129) Base excess in Capillary blood by calculation

146

780

1.89

11.69

2.3

0.77

0.53

mmol/l

0.36

135

745

(3023511) Choriogonadotropin [Units/volume] in Urine

293

1896

1.56

11.65

1.4

—

(3004775) Volume in Urine collected for unspecified duration

454

2.17

11.64

2.5

2.3

685.68

628.14

0.57

313

(3000963) Hemoglobin [Mass/volume] in Blood

8006

78437

1.50

11.57

39.3

22.6

135.29

136.05

g/l

4.37

7966

77773

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

423

2.21

11.57

1.1

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

108

3.53

11.51

5.9

6.1

47.79

42.30

ug/min

0.23

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

276

1768

1.58

11.47

1.6

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

113

558

2.04

11.38

1.5

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

350

2.32

11.38

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

320

2.39

11.32

1.4

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

402

2.22

11.27

27.4

29.1

111.36

122.92

ug/l

0.83

336

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

187

2.84

11.26

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

216

2.69

11.14

1.2

1.1

—

(3016750) Collection duration of Urine

341

2.33

11.13

2.6

2.3

515.18

495.86

min

0.78

260

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

275

2.48

11.06

1.3

1.2

110.92

108.91

0.22

247

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

276

2.47

10.98

3.3

3.6

1.49

1.29

0.26

276

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

212

2.70

10.98

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

218

2.67

10.95

1.2

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

189

1116

1.71

10.87

1.1

1.54

1.49

g/l

0.88

177

1021

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

402

2.20

10.86

1.6

1.5

7.33

5.99

u/l

0.43

328

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

203

3263

0.61

10.79

1.1

0.65

0.64

ratio

0.13

357

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

457

2.11

10.68

2.7

2.6

42.76

42.92

0.03

238

(3048929) Epstein Barr virus Ab [Presence] in Serum

457

3293

1.41

10.63

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

183

2.80

10.53

1.2

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

300

2.38

10.52

1.3

1.2

0.31

0.30

g/l

1.04

246

(3024869) Neuronal Ab [Presence] in Serum

105

3.44

10.51

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

751

9511

0.77

10.50

1.9

3.66

3.54

ratio

1.71

569

7208

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

318

2145

1.50

10.48

1.1

3.85

7.77

eliau/ml

1.11

292

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

149

833

1.80

10.38

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

248

2.51

10.34

1.5

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

225

2.59

10.31

1.4

108.77

120.74

nmol/l

0.31

166

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

614

1.93

10.29

2.4

2.7

—

(3049717) Cytology report of Urine Cyto stain

318

2157

1.49

10.21

2.5

2.6

—

(3017704) Immunofixation for Urine

317

2.31

10.18

1.6

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.01

10.18

4.0

2.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

2.93

10.13

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

182

1087

1.69

10.07

1.4

1.2

9.44

18.10

u/ml

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

3.60

10.04

1.5

1.2

34.81

60.56

1.97

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

196

1195

1.65

10.02

1.2

0.43

1.05

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

128

695

1.85

9.82

1.5

1.15

1.28

promille

0.46

554

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.52

9.73

1.3

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

195

1200

1.64

9.63

1.2

1.1

121.97

115.81

1.76

178

1096

(3011397) Hemoglobin [Presence] in Urine by Test strip

2024

17740

1.18

9.49

4.7

3.7

0.00

0.14

3.54

153

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

132

733

1.81

9.44

4.8

5.1

116.16

76.51

u/ml

0.27

231

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.68

9.39

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

122

664

1.85

9.32

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

954

7779

1.25

9.29

5.1

4.6

31.02

32.03

1.98

717

5381

(3028679) Herpes simplex virus Ab [Presence] in Serum

481

1.98

9.02

1.1

—

(3016879) Cocaine [Presence] in Urine

539

4107

1.33

8.87

4.6

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

286

2.28

8.85

1.1

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

200

1268

1.59

8.79

1.3

7.68

4.06

u/ml

1.22

575

(3044927) Protein electrophoresis panel - Urine

108

578

1.88

8.72

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

4.75

8.56

10.0

5.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

120

3.01

8.53

1.5

1.8

21.20

15.16

nmol/l

—

(4195642) Thrombophilia screening test

188

1185

1.60

8.48

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

105

3.15

8.46

1.3

1.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

105

3.15

8.46

1.2

1.3

39.25

44.15

mg/l

0.25

(1761482) Bacteria [#/volume] in Urine by Culture

211

1368

1.55

8.43

5.5

4.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

109

592

1.85

8.43

2.8

2.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

425

2.01

8.39

1.5

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

288

1997

1.46

8.34

1.3

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

353

2.10

8.29

1.1

—

0.13

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

241

3516

0.68

8.21

1.4

1.1

0.89

g/l

0.07

241

3509

(3014765) Yersinia sp identified in Stool by Organism specific culture

289

2012

1.45

8.20

1.3

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

112

619

1.82

8.20

4.2

4.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

491

1.92

8.20

1.1

1.2

1.06

ratio

0.12

401

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

285

1981

1.45

8.16

1.6

1.4

246.54

248.57

u/ml

0.04

195

1197

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

562

7159

0.77

8.16

1.7

1.6

3.43

3.49

mmol/l

0.67

393

4841

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

198

1277

1.56

8.12

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

298

2.19

8.06

1.5

2.1

579.60

15669.30

u/ml

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

273

2.24

8.02

1.0

1.1

101.81

88.91

3.44

134

(3000330) Specific gravity of Urine by Test strip

435

3268

1.35

7.90

4.1

3.2

1.02

ratio

0.21

397

2938

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

200

1303

1.55

7.85

1.3

3.39

3.46

u/ml

0.02

480

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

105

577

1.83

7.85

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

105

577

1.83

7.85

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

105

577

1.83

7.85

1.7

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

110

3.00

7.85

1.6

1.4

1.41

1.44

iu/ml

0.03

(42529406) Shigella sp [Presence] in Stool by Culture

288

2023

1.44

7.81

1.3

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

251

2.28

7.80

1.3

17.49

16.83

umol/l

0.38

215

(3005988) Vibrio sp identified in Specimen by Organism specific culture

141

847

1.67

7.74

1.7

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

563

4404

1.30

7.69

4.6

2.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

312

2.12

7.60

1.8

1.5

1.50

3.90

1.73

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

308

2206

1.41

7.51

1.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

294

2.15

7.51

1.1

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

314

2.11

7.49

2.2

2.4

155.97

149.16

nmol/l

0.21

275

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

116

667

1.75

7.48

1.1

308.55

284.41

mg/l

2.56

108

612

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

147

902

1.64

7.45

1.7

1.4

—

(4198724) Urine methamphetamine measurement

494

1.87

7.42

2.4

2.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

322

2.09

7.41

1.0

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

145

888

1.64

7.41

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

145

888

1.64

7.41

1.7

1.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

1.94

2.71

mg/l

0.37

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

0.38

1.25

mg/l

2.56

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

0.88

1.81

mg/l

0.90

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

1.35

1.59

mg/l

0.21

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

1.52

2.24

mg/l

0.36

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

3.07

3.87

mg/l

0.31

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

0.95

0.87

mg/l

0.08

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

1.56

1.50

mg/l

0.03

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.12

7.37

1.8

3.26

4.95

mg/l

0.78

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

425

1.94

7.36

1.3

1.2

86.20

99.78

u/l

0.66

359

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

412

1.95

7.32

1.3

1.2

27.46

26.47

u/l

0.07

344

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

419

1.94

7.32

1.5

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

107

605

1.78

7.31

2.4

2.7

0.70

0.72

e9/l

0.10

587

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

139

845

1.65

7.31

1.7

1.4

—

(3008898) HLA-B27 [Presence]

410

3091

1.34

7.29

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

379

1.99

7.25

1.1

2.00

13.84

u/ml

—

(3045142) Bone marrow Pathology biopsy report

131

787

1.67

7.22

1.4

—

(3028300) Cannabinoids [Presence] in Urine

562

4437

1.28

7.16

4.7

2.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.06

7.13

1.8

1.11

1.21

mg/l

0.07

(3027008) Opiates [Presence] in Urine

560

4424

1.28

7.10

4.5

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

137

840

1.64

6.99

1.7

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

497

1.84

6.99

1.1

—

0.35

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

6.96

6.97

1.2

1.1

1.20

1.12

u/field

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.78

6.78

8.1

9.2

—

(3028433) Virus identified in Specimen by Culture

241

2.20

6.77

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

385

1.93

6.61

2.8

2.6

61.45

53.52

umol/l

0.92

353

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

6.40

6.61

1.4

1.3

1.61

1.40

0.97

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

383

2905

1.33

6.57

1.5

1.7

11.74

13.45

u/ml

0.29

761

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

264

2.13

6.55

1.0

1.2

109.21

85.86

3.73

130

(3013637) Mi-2 Ab [Presence] in Serum

200

2.30

6.54

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

200

2.30

6.54

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

200

2.30

6.54

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

200

2.30

6.54

1.3

1.1

—

(3021788) Differential panel - Synovial fluid

189

1275

1.49

6.39

1.8

1.5

—

1.00

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

113

2.75

6.34

3.4

4.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.05

6.33

1.8

1.4

690.40

517.06

nmol/l

0.44

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

485

1.80

6.30

2.4

2.0

1.40

1.62

u/field

0.35

268

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

249

2.13

6.27

3.2

2.7

0.61

mmol/l

0.14

249

(4024509) Urine culture

406

3139

1.31

6.11

2.2

1.9

—

(3027944) Amphetamines [Presence] in Urine

545

4375

1.26

6.09

3.6

2.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.10

6.07

1.8

2.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

355

1.92

6.05

2.1

2.9

64.74

49.87

umol/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

323

1.96

5.92

1.9

1.7

0.69

3.33

u/field

3.44

238

(40768441) Liver Pathology biopsy report

579

1.70

5.83

1.6

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.94

5.81

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

264

2.05

5.80

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6075

62676

0.88

5.78

31.1

18.7

332.52

332.93

g/l

2.92

6046

62349

(4268621) Lupus anticoagulant assay

142

923

1.55

5.75

2.5

2.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

233

1673

1.40

5.70

1.8

1.6

13568.07

13380.51

e6/l

0.02

166

1170

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

156

2.38

5.68

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

378

2935

1.30

5.54

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

348

4481

0.77

5.53

1.5

1.6

999.98

1006.88

mu/l

0.05

298

3790

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

116

2.59

5.52

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.73

5.50

1.4

1.7

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.62

5.46

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

178

2.25

5.45

2.2

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

107

661

1.63

5.40

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

140

921

1.53

5.40

1.5

1.3

—

(1002224) Polysomnography panel

502

4052

1.25

5.38

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

342

1.88

5.36

1.9

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

342

1.88

5.36

1.9

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

342

1.88

5.36

1.9

1.8

—

(3012898) Urea [Moles/volume] in Urine

2.86

5.33

1.7

1.5

178.63

170.98

mmol/l

0.09

(3033099) Centromere Ab [Titer] in Serum

161

2.30

5.32

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

343

1.87

5.32

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

246

2.04

5.31

2.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

246

2.04

5.31

2.1

2.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

294

1.94

5.31

2.4

2.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.98

5.23

6.9

5.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

2364

1.32

5.20

1.2

3.38

4.04

0.75

329

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

122

787

1.56

5.16

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

249

2.01

5.15

2.1

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.94

5.12

7.0

6.1

79297.50

569115.79

u/ml

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

112

711

1.58

5.08

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

110

697

1.58

5.03

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

357

1.83

5.02

2.5

1.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

117

753

1.56

5.01

1.4

1.2

22.89

41.65

u/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

343

1.84

5.01

1.0

1.1

103.79

93.26

1.46

275

(3018333) Ribosomal P Ab [Presence] in Serum

103

646

1.60

4.93

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

154

2.28

4.93

1.9

2.2

—

(3046861) Legionella sp Ag [Presence] in Urine

4.33

4.92

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

108

686

1.58

4.90

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

3.12

4.89

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.66

4.89

1.8

1.4

0.39

0.55

iu/ml

0.45

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

108

687

1.58

4.88

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.48

4.88

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

227

2.03

4.87

1.4

1.5

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.33

4.87

1.2

1.1

1.54

4.80

u/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.77

4.85

1.2

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

112

2.50

4.85

2.1

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.61

4.70

11.7

5.06

5.79

mmol/l

0.63

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.84

4.63

1.3

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

127

2.36

4.62

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

434

1.71

4.61

7.1

7.2

9.98

95.29

ug/l

1.07

294

(40762814) Titanium [Mass/volume] in Blood

2.75

4.59

2.7

2.4

3.88

3.94

ug/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

120

795

1.52

4.55

1.1

—

(3042733) HLA Ab [Presence] in Serum

318

1.83

4.54

4.8

4.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

104

668

1.56

4.53

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

117

2.40

4.45

1.8

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

515

1.64

4.45

1.4

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1880

17173

1.12

4.44

1.8

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1182

10502

1.14

4.34

2.3

2.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

184

2.07

4.28

1.3

1.2

4.59

12.17

pmol/l

2.41

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

109

718

1.52

4.27

1.6

1.5

74.56

78.70

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

291

1.82

4.16

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

291

1.82

4.16

1.6

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

132

910

1.46

4.15

1.2

1.1

100.67

96.96

0.78

124

856

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

627

1.55

4.15

2.8

2.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

180

1313

1.38

4.13

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

746

6444

1.17

4.01

3.5

4.4

30.56

25.43

ug/l

0.14

587

5141

(3043238) Trisomy 21 risk [Likelihood] in Fetus

141

1974

0.71

4.01

1.5

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

184

1357

1.36

3.96

3.2

3.8

376.21

694.84

u/ml

0.57

160

1236

(3012494) Peanut IgE Ab [Units/volume] in Serum

341

1.73

3.93

1.1

1.2

6.29

13.14

u/ml

0.34

227

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

131

2.22

3.90

1.4

1.7

10.57

346795.11

nmol/l

1.08

109

(3006270) Folate [Moles/volume] in Blood

534

1.58

3.89

1.1

361.13

379.87

nmol/l

0.34

479

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

189

2511

0.75

3.87

1.5

62.83

60.14

ug/l

0.33

164

2099

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.78

3.86

1.3

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

132

2.20

3.84

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

176

2356

0.74

3.80

1.4

1.5

0.93

0.95

ratio

0.24

106

1423

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

176

2356

0.74

3.80

1.4

1.5

1.12

1.22

ratio

0.89

106

1434

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.47

3.78

1.1

1.0

—

(44813793) Dust mix specific IgE antibody measurement

610

1.53

3.76

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

12.00

3.76

1.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

547

1.56

3.75

1.2

1.4

415.87

364.68

u/l

0.34

525

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

208

1.93

3.74

5.2

3.9

4.99

4.89

kpa

0.29

208

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

208

1.93

3.74

5.2

3.9

9.93

10.42

kpa

0.43

208

(3047352) Trisomy 18 risk [Likelihood] in Fetus

139

1925

0.72

3.73

1.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

339

1.71

3.73

2.7

3.5

159.13

116.34

au/ml

0.29

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

176

2349

0.74

3.73

1.4

1.5

1.06

1.14

ratio

0.75

106

1416

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

331

2671

1.25

3.67

2.1

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

103

695

1.49

3.66

1.3

1.4

9.31

8.35

mmol/l

1.06

665

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

182

1.98

3.65

1.1

1.2

90.63

79.52

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.62

3.65

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

488

1.58

3.63

1.1

1493.56

1513.51

miu/ml

0.06

488

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

174

2314

0.75

3.61

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

505

1.57

3.60

1.1

1.0

—

(3005033) Fetal Nuchal fold Thickness US

137

1887

0.72

3.58

1.5

1.19

1.26

1.40

103

1358

(3024891) Influenza virus A+B Ag [Presence] in Specimen

294

2348

1.26

3.57

1.2

1.1

—

(3036180) Methadone [Presence] in Urine

4.76

3.55

2.0

2.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

612

1.51

3.51

1.2

1.4

6.56

6.24

mmol/l

0.46

575

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

131

2.14

3.49

1.0

90.03

77.74

ug/l

0.58

109

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.32

3.48

1.1

0.74

0.58

u/ml

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

159

2.01

3.42

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

114

796

1.44

3.42

1.4

1.5

29.89

33.36

g/l

1.94

107

722

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

100

681

1.47

3.42

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

194

1.91

3.41

1.0

1.1

—

208.00

—

(4038314) Semen analysis, post vasectomy

2.76

3.41

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1264

11450

1.12

3.40

2.3

2.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

233

2954

0.78

3.40

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

110

765

1.44

3.38

1.9

2.1

25.41

22.53

mg/l

0.17

281

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.44

3.37

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

143

1043

1.38

3.36

1.9

693.33

1523.14

titre

—

(3035880) pH of Pleural fluid

305

1.71

3.34

1.2

1.4

7.43

7.39

0.86

210

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.32

3.32

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

182

1.93

3.31

1.0

1.2

76.17

67.00

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.36

3.30

5.8

5.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.62

3.29

1.1

1.0

—

(3019174) dRVVT (LA screen)

2.62

3.29

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.92

3.29

1.1

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.64

3.28

1.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.64

3.28

7.5

3.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

593

5117

1.17

3.28

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

109

2.20

3.23

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

456

1.56

3.21

1.8

1.4

24.38

22.03

u/ml

0.11

(3017315) Amylase [Enzymatic activity/volume] in Urine

363

1.63

3.19

1.8

1.3

196.54

331.05

u/l

1.71

334

(3005532) Lymphocytes/Leukocytes in Pleural fluid

206

1.85

3.19

1.5

62.73

63.54

0.05

169

(3022621) pH of Urine by Test strip

655

5710

1.16

3.18

3.0

2.5

6.13

6.10

0.43

424

3718

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

104

2.21

3.14

1.6

1.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

373

1.61

3.12

3.1

4.7

10.02

8.87

mg/l

0.30

299

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

111

2.16

3.11

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

3.67

3.08

1.0

1.2

77.60

215.10

pmol/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.67

3.08

1.0

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

125

2.08

3.06

1.1

1.2

0.72

140.80

mg/l

1.47

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.22

3.04

6.0

5.0

30.59

22.22

mg/l

1.53

(3051651) Icteric interference index of Serum or Plasma

455

1.54

3.03

4.2

3.8

0.74

0.83

index

0.38

450

(21494434) Karyotype in Bone marrow

593

1.47

3.01

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

233

1.76

2.98

1.3

1.2

—

(4034850) Laboratory test

257

2070

1.25

2.97

11.6

9.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

362

3025

1.20

2.93

1.3

202.87

226.99

miu/ml

0.58

136

1415

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

419

1.55

2.93

1.2

1.3

15.17

12.28

u/l

0.45

388

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

437

3715

1.18

2.92

3.0

3.4

94.86

56.21

u/ml

0.24

418

3597

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

420

1.55

2.90

1.0

237.32

314.02

ng/l

3.15

298

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

420

1.55

2.90

1.0

822.31

759.02

ng/l

0.58

286

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

163

1.90

2.88

1.5

1.3

42.92

37.69

0.38

107

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

422

1.54

2.85

1.0

32.56

41.17

ng/l

1.48

294

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

237

1.73

2.83

2.6

2.7

26.68

28.28

umol/l

0.48

166

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

471

1.51

2.82

2.0

1.8

25.46

565.66

pmol/l

1.45

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.64

2.78

1.1

9.14

14.28

u/l

0.33

(3036670) Protein [Mass/volume] in Synovial fluid

181

1.82

2.71

1.3

1.2

35.62

39.98

g/l

0.93

(3005570) Glucose [Moles/volume] in Urine

650

1.42

2.68

2.0

—

0.93

—

(3016135) IgD [Mass/volume] in Serum

4.21

2.67

1.6

1.2

267.69

34.07

mg/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

685

1.40

2.64

1.1

1.3

171.88

192.78

titre

0.10

133

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

140

1.93

2.63

3.6

2.7

4.04

248.78

ug/l

0.64

140

(3003888) Timothy IgE Ab [Units/volume] in Serum

254

2074

1.23

2.63

1.1

3.64

5.91

u/ml

2.07

123

1228

(1761868) Lipid panel - Serum or Plasma

3135

29917

1.08

2.62

3.6

2.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

165

1281

1.29

2.62

2.1

2.2

1.33

12.74

titre

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

206

1.75

2.59

4.1

2.0

0.78

1.56

mmol/l

2.10

157

(4015189) Microbial culture of sputum

127

1.97

2.59

2.5

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

463

4000

1.17

2.58

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

158

1223

1.30

2.57

1.1

3.37

3.78

eliau/ml

0.17

573

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

284

2355

1.21

2.54

1.2

2.89

2.28

u/ml

0.37

158

1353

(43055442) Apixaban [Mass/volume] in Serum or Plasma

2.13

2.53

1.5

155.54

123.54

ug/l

0.46

(3032868) Hemoglobin electrophoresis panel in Blood

2.13

2.53

1.6

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

163

1270

1.29

2.53

2.7

2.8

7.69

7.86

umol/l

0.05

131

960

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

588

0.59

2.51

1.4

1.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.23

2.51

1.2

1.0

0.14

0.12

u/ml

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

343

2899

1.19

2.50

1.8

1.7

4.74

4.28

mg/l

0.27

273

2123

(3018738) Hemoglobin F/Hemoglobin.total in Blood

115

2.00

2.49

2.3

3.6

3.39

3.49

0.02

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1240

0.72

2.47

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

536

4702

1.15

2.45

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.67

2.44

1.4

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.89

2.40

3.8

4.8

—

(40757373) Influenza virus identified in Isolate

124

1.94

2.39

1.7

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

733

1.37

2.38

1.3

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

393

1.50

2.36

1.2

2.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

393

1.50

2.36

1.2

2.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

104

2.02

2.35

1.1

0.01

0.04

u/ml

1.14

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

213

1.69

2.34

1.7

1.6

9.69

8.75

ug/l

0.51

213

(3013466) aPTT in Blood by Coagulation assay

2.82

2.33

1.1

32.09

36.65

4.61

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.25

2.33

1.4

3.2

1.43

1.41

mg/l

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

119

1.93

2.29

3.1

2.1

7.35

7.46

mmol/l

0.06

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.22

2.26

1.1

0.03

u/ml

0.00

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

184

1478

1.25

2.26

1.6

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

186

1.72

2.22

1.2

—

(3024316) Viscosity of Plasma

2.86

2.20

1.1

1.7

1.35

1.76

mpas

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.68

2.20

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

242

2009

1.21

2.19

1.1

1.10

1.11

u/ml

0.01

1021

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.33

2.17

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.33

2.17

6.8

9.6

—

(3003694) ABO and Rh group [Type] in Blood

2343

22261

1.07

2.14

1.5

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

108

1.94

2.14

1.2

1.3

40.94

62.21

ng/l

0.34

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.78

2.13

1.2

1.0

0.12

0.13

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

354

1.50

2.12

4.3

5.9

65.79

666.91

mg/l

0.50

279

(3005082) Progesterone [Moles/volume] in Serum or Plasma

511

1.41

2.11

1.3

1.5

34.63

37.30

nmol/l

0.20

455

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.10

2.11

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

283

1.56

2.09

2.8

1.8

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

405

1.46

2.07

1.6

1.3

210.00

606.90

titre

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.50

2.05

1.0

1.2

43.33

36.19

umol/24h

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.17

2.03

1.0

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

391

1.46

2.02

1.5

1.3

77.14

66.67

titre

—

(44806071) Cardiolipin IgM antibody measurement

125

1.84

2.01

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

644

1.35

2.01

1.3

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

2.00

1.1

—

(3020650) Glucose [Presence] in Urine

271

1.55

1.98

2.1

1.6

0.07

0.04

estimate

0.14

271

(40768795) Lymph node Pathology biopsy report

672

1.34

1.97

1.3

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

243

0.45

1.95

2.2

3.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

278

2367

1.18

1.94

3.1

3.7

546.45

2376.44

u/ml

0.83

228

2049

(3032641) Amino acids panel - Urine

2.73

1.92

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

189

1556

1.22

1.90

1.1

3.89

6.12

u/ml

0.91

760

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

574

1.36

1.89

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.18

1.87

1.3

1.1

2.14

3.05

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.31

1.87

3.2

6.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.31

1.87

3.6

3.4

—

(44806420) Estimation of glomerular filtration rate

113

880

1.29

1.85

2.6

2.4

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

2.39

1.84

1.5

1.9

52.67

51.03

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

182

1.65

1.83

1.7

1.3

56.95

52.35

0.24

153

(3050794) Legionella sp Ab [Presence] in Serum

2.20

1.83

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

164

1337

1.23

1.83

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

716

1.32

1.82

1.1

1.2

4.30

2.32

u/ml

0.48

297

(40768806) Pleura Pathology biopsy report

615

1.34

1.77

1.4

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

703

1.31

1.75

4.3

3.5

14.74

14.25

index

0.14

450

(3019832) Treponema pallidum Ab [Presence] in Serum

1042

9675

1.09

1.75

1.9

1.8

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

224

1.56

1.74

2.2

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

135

1667

0.81

1.73

1.4

1.5

58.57

59.70

ug/l

0.13

135

1667

(36303858) Crystals [Presence] in Urine

3.84

1.71

1.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.70

0.0

1.3

—

1.66

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.68

1.0

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

187

1.60

1.67

1.8

1.6

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.58

1.65

3.5

3.3

4.20

4.63

mmol/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.80

1.64

1.0

—

(3049233) Organic acids panel - Urine

2.24

1.63

1.0

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.84

1.60

1.2

1.3

0.60

1.83

mmol/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

179

2127

0.84

1.58

1.4

1.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.00

1.58

1.2

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.69

1.57

1.3

2.2

207.43

280.23

ug/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

196

1655

1.19

1.57

1.1

3.32

4.63

u/ml

0.50

880

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.20

1.56

1.1

2.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

114

1.75

1.55

1.1

1.2

1.28

1.70

mmol/l

—

(3023199) Leukocytes [#/volume] in Pleural fluid

718

1.28

1.54

1.4

1.5

6368.31

3656.17

e6/l

0.27

501

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

248

1.49

1.53

1.6

1.7

40.71

40.12

g/l

0.24

248

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

634

5799

1.10

1.52

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

155

1286

1.21

1.51

1.1

2.20

2.80

0.44

217

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

753

6947

1.09

1.50

2.3

2.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

154

1.62

1.49

1.2

1.3

329.41

339.37

ug/l

0.01

(3010144) Erythrocytes [#/volume] in Synovial fluid

599

1.30

1.48

1.7

1.4

28285.14

88429.94

e6/l

1.47

407

(3026051) Granulocytes/Leukocytes in Pleural fluid

124

1.69

1.46

1.5

1.4

17.19

25.01

0.71

102

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

163

1.60

1.45

3.3

3.8

51.27

66.65

u/l

0.45

157

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

127

1038

1.23

1.45

2.4

2.5

37.53

27.39

iu/ml

0.28

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.84

1.45

2.4

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.50

1.45

3.1

5.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

422

1.35

1.40

1.3

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

153

1279

1.20

1.40

1.6

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.17

1.39

1.1

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.19

1.36

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.34

0.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

183

1.53

1.33

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

592

1.29

1.33

1.7

1.8

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.50

1.30

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.35

1.29

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

693

1.26

1.28

1.1

1.2

4.21

7.35

u/ml

0.33

239

(4094501) Cardiovascular stress test using bicycle ergometer

225

1963

1.15

1.25

1.1

—

(4146454) Self-monitoring of blood glucose

626

1.26

1.23

2.6

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

424

1.32

1.22

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

195

1689

1.16

1.21

1.3

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

330

1.36

1.21

1.1

4.72

9.55

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

156

1.54

1.19

1.4

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

1.74

1.18

1.5

1.6

6.13

8.36

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

124

1037

1.20

1.18

3.1

3.3

0.79

0.81

nmol/l

0.16

827

(3024263) Appearance of Synovial fluid

335

1.34

1.12

1.8

1.7

—

(3017509) Phencyclidine [Presence] in Urine

103

1.65

1.12

1.9

1.6

—

(3025577) Chromium [Mass/volume] in Blood

320

1.34

1.08

2.2

2.3

2.59

2.60

ug/l

0.00

267

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

166

0.54

1.07

1.4

1.2

74.33

69.63

ug/l

—

166

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.92

1.05

1.1

1.6

346.30

322.96

umol/24h

—

(3024932) HLA-DR beta [Type]

288

1.35

1.04

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

297

1.35

1.03

1.3

1.2

—

(3048879) Bone marrow aspiration report

154

1.49

1.03

1.6

1.9

—

2.00

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

114

1.58

1.02

1.3

4.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

403

1.29

1.00

1.3

1.2

13.12

8.83

mm/h

1.01

403

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.87

1.00

3.1

2.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.76

1.00

6.8

4.6

100.58

101.01

g/l

0.06

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.00

1.00

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

115

1.56

0.99

1.6

1.2

56.28

65.46

ug/l

1.19

115

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

2.17

0.98

1.2

1.0

—

0.22

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.17

0.98

1.2

37.98

30.79

mg/24h

—

(3024471) HLA-A [Type]

292

1.34

0.96

1.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

184

1624

1.13

0.93

1.2

1.1

22.86

16.26

au/ml

0.34

389

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

295

1.32

0.91

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

161

1415

1.14

0.88

1.1

0.07

0.62

u/ml

2.38

514

(3038071) Oxygen [Partial pressure] in Mixed venous blood

185

1.41

0.88

10.8

6.1

5.28

kpa

0.00

185

(3009015) Lactate [Moles/volume] in Synovial fluid

1.69

0.88

1.1

1.2

4.02

6.01

mmol/l

—

(3045788) Cell count panel - Pleural fluid

601

1.22

0.88

1.3

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

333

1.29

0.86

2.8

2.5

9.12

9.47

mg/l

0.17

286

(3026470) Cobalt [Mass/volume] in Blood

327

1.28

0.82

2.4

2.2

3.83

3.50

ug/l

0.10

304

(3022670) pH of Venous cord blood

1.74

0.82

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.64

0.81

1.6

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

1.70

0.80

1.6

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

321

2951

1.09

0.80

1.7

1.9

—

32.21

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

409

1.25

0.80

1.1

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

250

1.32

0.79

2.2

1.9

224.36

127.85

au/ml

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.67

0.78

1.1

1.0

—

19.00

iu/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

601

1.20

0.78

3.3

2.5

17.95

27.85

mg/l

3.06

414

(40760409) HLA-A [Type] by High resolution

1.76

0.76

1.0

—

(40760410) HLA-B [Type] by High resolution

1.76

0.76

1.0

—

(40763590) HLA-DQ beta [Type]

1.76

0.76

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.76

0.76

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

220

1993

1.11

0.76

1.1

1.48

2.26

u/ml

0.83

108

1128

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.70

0.75

1.1

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.08

0.74

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

116

1.46

0.73

1.0

1.1

0.32

0.10

u/ml

0.42

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

134

0.60

0.73

1.0

1.1

6.28

5.86

u/ml

—

134

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.79

0.72

1.4

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

174

1931

0.90

0.72

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

625

1.18

0.72

1.1

0.59

1.67

u/ml

0.71

207

(3013762) Body weight Measured

1.92

0.70

1.0

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

101

1.48

0.69

1.0

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

135

1.41

0.68

3.2

2.9

909.95

1546.01

u/l

0.31

124

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

330

0.76

0.68

1.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.85

0.68

1.2

1.0

—

0.15

u/ml

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

127

1.42

0.67

1.0

1.1

0.13

0.64

u/ml

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

157

1409

1.12

0.67

4.4

3.3

24.72

26.09

mg/l

0.26

117

958

(3012441) Differential panel - Pleural fluid

622

1.17

0.66

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.54

0.65

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

633

1.17

0.64

1.4

1.5

104659.37

60810.83

e6/l

0.32

352

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.72

0.63

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.72

0.63

1.0

1.2

0.00

0.87

u/ml

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

138

1.38

0.62

1.0

1.1

0.06

3.85

u/ml

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

121

1.40

0.61

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

164

0.67

0.61

1.6

1.3

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.67

0.61

1.2

1.0

—

0.09

u/ml

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

182

1.32

0.60

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

182

1.32

0.60

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

182

1.32

0.60

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.60

0.0

1.3

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.54

0.59

1.8

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

272

1.25

0.58

1.0

1.3

4.35

11.03

u/ml

1.03

195

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.58

0.0

1.2

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

140

1.36

0.58

1.0

1.1

0.02

1.87

u/ml

—

(3013862) HLA-DP [Type]

1.71

0.57

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.46

0.57

3.7

6.7

7.42

8.10

mmol/l

0.79

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

158

1.33

0.56

1.7

2.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.67

0.56

7.7

4.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.67

0.56

5.2

9.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

129

1160

1.11

0.56

1.7

1.5

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.45

0.56

1.4

1.2

—

(3044007) Cell count panel - Peritoneal fluid

228

0.74

0.54

2.0

1.9

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

151

1.32

0.53

1.2

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

1.49

0.53

1.0

0.10

0.18

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

134

0.67

0.51

1.3

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.50

0.51

1.0

1.1

—

26.59

—

(3000034) Microalbumin [Mass/volume] in Urine

564

1.15

0.51

3.2

2.9

54.95

51.37

mg/l

0.04

424

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

101

1.39

0.49

1.1

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

136

1.32

0.48

1.2

—

(3022475) Manganese [Moles/volume] in Blood

1.46

0.46

1.1

1.3

0.16

0.17

umol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

221

0.77

0.46

1.9

22049.67

14088.80

e6/l

—

113

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.37

0.44

1.3

1.0

—

(4281824) Cell count and differential, peritoneal fluid

714

0.88

0.44

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.43

0.42

1.1

—

4.25

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

396

1.16

0.42

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.38

0.42

1.1

1.3

102.57

395.64

u/l

—

(40765096) Chromosome analysis panel by Banding

212

1.23

0.41

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

186

1.24

0.40

1.2

1.4

12.43

g/l

0.00

135

(3009677) Dengue virus Ab [Presence] in Serum

1.43

0.39

1.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

750

1.11

0.38

1.1

9.26

8.29

iu/ml

0.17

200

(3034426) Prothrombin time (PT)

279

1.18

0.38

1.3

29.03

28.41

0.18

279

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

284

2695

1.05

0.38

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

327

1.16

0.36

1.4

1.5

0.57

0.51

e9/l

0.67

327

(3023487) Leukocytes [#/volume] in Peritoneal fluid

256

0.82

0.36

2.0

2.1

888.12

683.39

e6/l

0.22

174

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.27

0.36

1.2

1.1

99.56

88.79

titre

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.33

0.35

1.2

1.0

—

(40768793) Breast Pathology biopsy report

157

1674

0.94

0.34

1.3

—

(4133840) Spirometry

200

0.80

0.34

1.1

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

100

1.30

0.33

1.2

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

312

1.15

0.32

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

389

1.13

0.31

6.3

7.1

7216.38

8685.69

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.32

0.30

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

185

0.81

0.30

1.7

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.29

0.29

1.9

2.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

173

1635

1.06

0.29

1.4

1.5

90.95

146.60

pmol/l

2.03

167

1593

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

292

0.85

0.29

2.1

1.8

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

121

1.24

0.28

1.0

1.2

0.01

0.52

u/ml

1.39

121

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.28

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

149

1.21

0.27

1.3

1.16

1.17

mmol/l

0.30

149

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

134

1261

1.06

0.27

1.3

—

(3006598) pH of Arterial cord blood

161

0.81

0.27

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

111

1041

1.07

0.25

1.2

1.4

7.59

7.08

mmol/l

0.85

103

940

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

114

1.23

0.25

14.4

6.9

9.59

10.78

1.73

114

(40768800) Prostate Pathology biopsy report

103

1092

0.94

0.22

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.77

0.22

1.0

1.1

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

296

1.11

0.21

1.1

1.0

10.09

12.72

u/ml

0.29

198

(3025018) Bordetella pertussis Ab [Titer] in Serum

720

1.07

0.21

1.2

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.21

0.0

1.1

—

0.28

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.0

—

(4212803) Bone marrow aspirate examination

1.20

0.19

1.0

1.1

—

(3001729) Color of Synovial fluid

1.15

0.19

2.8

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.22

0.19

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

247

0.89

0.17

1.1

1.2

36.72

6.70

u/ml

0.46

229

(3002619) Bacteria identified in Specimen by Culture

195

1.13

0.17

1.3

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.76

0.17

1.0

167.40

162.94

g/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

741

0.94

0.16

1.1

13.69

16.72

u/ml

0.59

285

(3025130) Human papilloma virus identified in Specimen

121

1261

0.96

0.16

1.7

1.9

—

(3006462) Nitrate [Presence] in Urine

311

1.09

0.16

3.7

3.1

—

(3014891) Appearance of Pleural fluid

1.09

0.15

2.0

1.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.12

0.15

1.9

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

343

1.08

0.14

1.7

2968.89

2990.64

titre

—

(3020491) Glucose [Moles/volume] in Blood

529

1.06

0.13

1.4

1.7

7.01

6.35

mmol/l

0.96

387

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

117

0.85

0.13

1.6

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

186

1808

1.03

0.13

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

138

1335

1.03

0.12

1.1

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

104

1.15

0.12

1.0

1.1

2.78

8.18

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

186

1810

1.03

0.12

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

282

0.92

0.12

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

105

1.14

0.11

1.8

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

493

0.95

0.09

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.06

0.09

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

451

0.95

0.09

1.3

1.9

0.54

2.97

u/ml

—

139

(4211845) Urine protein measurement

341

1.05

0.08

3.6

3.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.78

0.08

1.0

1.1

1.22

1.31

mom

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

257

2603

0.99

0.07

1.4

1.5

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.87

0.06

19.4

8.6

0.38

0.19

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.12

0.06

1.0

1.2

7.52

5.69

mmol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

423

4266

0.99

0.06

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

440

1.02

0.02

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

343

1.02

0.01

1.2

611.11

985.07

titre

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

404

1.01

0.00

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

252

0.99

0.00

6.9

6.2

11.32

8.56

1.29

252

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

252

0.99

0.00

1.1

28.85

36.09

iu/ml

0.42

252

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

313

0.99

0.00

2.1

2.0

96.46

184.71

ug/min

0.52

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

119

1.01

0.00

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

253

0.99

0.00

3.4

3.1

32.24

43.95

2.16

253

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

19.20

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.81

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.9

—

11.62

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1482.50

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

2.0

—

0.06

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

1.00

-0.00

1.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

41.20

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_PCOS_BROAD_EXCLUSIONS – Exclusions for E4_PCOS_BROAD

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Exclusions for E4_PCOS_BROAD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Exclusions for E4_PCOS_BROAD (E4_PCOS_BROAD_EXCLUSIONS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints